{"docstore/data":{"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_1":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_1\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                         CG LABORATORIES, Inc. (CGL)\\n Document No.:      82005       Revision:    M        Page:       1       of      27\\n Title:             Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nTable of Contents\\nPurpose…………………………………….Page 2                        Review Output………………………….Page 11\\nScope………………………………………Page 2                          Resource Management………………Page 12\\nReferences………………………………..Page 2                      Provision of Resources…………………Page 12\\nQuality Management System (QMS)...Page 3            Human Resources…………………...…Page 12\\nGeneral Requirements………………….Page 3                  Competence, Awareness and Training..Page 12\\nDocumentation Requirements…….....Page 3             Infrastructure…………………………….Page 13\\nGeneral……………………………………Page 4                         Work Environment…………………...…Page 13\\nQuality Manual…………………………..Page 4                    Product Realization……………………Page 14\\nControl of Document…………………...Page 4                 Planning of Product Realization……..Page 14\\nControl of Records………………………Page 4                   Customer-Related Processes………Page 15\\nManagement Responsibility…………...Page 4              Determination of Requirements Related to\\nManagement Commitment…………..Page 4                   the Product…………………………….Page 15\\nCustomer Focus………………………….Page 4                     Review of Requirements Related to the\\nQuality Policy……………………………..Page 5                   Product………………………………….Page 15\\nPlanning……………………………………Page 5                        Customer Communication………….Page 15\\nQuality Objectives……………………….Page 5                  Purchasing Controls………………….Page 16\\nQuality Management System Planning  Page 7          Purchasing Process…………………..Page 16\\nResponsibility, Authority and Communication Page 9  Purchasing Information………………Page 16\\nResponsibility and Authority……………Page 9             Verification of Purchased Product…Page 17\\nManagement Representative……...Page 10               Production and Service Provision…..Page 17\\nInternal Communication…………….Page 10                 Control of Production and Service Provision Page 17\\nManagement Review………………..Page 11                    Validation of Processes for Production and\\nGeneral…………………………………Page 11                         Service Provision……………………….Page    18\\nReview Input……………………………Page 11\\nIdentification and Traceability……………..…..  Page 19\\nCustomer Property………….………………….....         Page 19\\nPreservation of Product……………………….….        Page 20\\nInspection, Measuring and Test Equipment…  Page 20\\nMeasure, Analysis and Improvement…………      Page 21\\nGeneral …………………………………………….                 Page 21\\nMonitoring and Measurement …………………         Page 21\\nCustomer Satisfaction ……………………………          Page 21\\nInternal Audit ………………………………………             Page 22\\nMonitoring and Measurement of Processes …  Page 22\\nMonitoring and Measurement of Product ……   Page 23\\nControl of Nonconforming Product …………..    Page 24\\nAnalysis of Data …………………………………..           Page 25\\nImprovement ……………………………………..               Page 25\\nContinual Improvement …………………………           Page 25\\nCorrective Action ………………………………..           Page 26\\nPreventive Action ………………………………..           Page 26\\nStatistical Techniques …………………………...       Page 27\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"XkUvjhfBLbDIA7i1VcxsaIgv28DigHEgaKr8nDMDwMg=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_2":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_2\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005        Revision:     M         Page:        2        of      27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nPurpose\\nCGL is a medical device company all falls under the jurisdiction of FDA as stated in 21 CFR, Part\\n820. CGL is a contract packaging company, providing decontamination, and laboratory\\nservices such as biological, bioburden, sterility, and physical testing for the medical device\\nindustry. This Quality Manual outlines policies, procedures and responsibilities for implementing\\nand managing quality related activities for CG LABORATORIES. This manual describes our\\nQuality Management System (QMS) and reflects all elements of the ISO 13485:2003 International\\nStandard and the cGMP-QSR (21 CFR, Part 820).\\nThe Process Owner of Quality Systems will coordinate the review and re-issue of the manual at\\nleast once each calendar year to insure that current practices are reflected and continual\\nimprovement of the QMS is pursued. Changes occurring between reviews will be documented\\nand filed. The appropriate personnel will be notified of the changes through documented\\nprocedures outlined in this manual.\\nExclusion is claimed to the Installation (7.5.1.2.2) and Service Provision (7.5.1.2.3), Implantable\\nDevices (7.5.3.2.2). and Design Provision (7.3) of this standard. CGL does not manufacture\\ndevices requiring Installation and Servicing nor does it manufacture implantable devices.\\nDesign is not performed at CGL because is provided specifications by Customers. These are not\\naspects of the CGL Business Strategy.\\nFor information regarding this manual, write to CG LABORATORIES, Granbury, TX.\\nScope\\nThis Quality Manual and the information contained herein directly affect all company\\ndepartments, the CGL QMS and ISO 13485: 2003 International Standard and the cGMP-QSR.\\nThis manual describes the manners in which CG LABORATORIES will consistently provide product\\nthat meets or exceeds customer and applicable regulatory requirements, and how all\\ncompany personnel contribute to the constant drive towards the enhancement of customer\\nsatisfaction. This will be demonstrated by actions such as:\\n      effective application of the system\\n      effective application of continual improvement processes\\n      assurance to conformity to customer and applicable regulatory requirements\\nAll copies of this document, which are externally distributed, will be uncontrolled.\\nCG Laboratories has two facilities;\\n      1410 Southtown Granbury, TX 76048\\n      2249 Bob White Granbury, TX 76049\\nCGL performs decontamination and medical device testing at 1410 Southtown and medical\\ndevice manufacturing and packaging at 2449 Bob White.\\nReferences\\nAll applicable level 2 reference documentation is contained at the conclusion of each Quality\\nManual section contained within the manual overview. Certain sections may also contain\\ndocumentation references within the text body.\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"Z8ftV1u05KqnnGwCqSgHFaTNGN+wECJbOoPPt0ZZErg=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_3":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_3\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                          CG LABORATORIES, Inc. (CGL)\\nDocument No.:       82005        Revision:    M         Page:       3        of      27\\nTitle:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nQuality Management System (QMS)\\nGeneral Requirements\\nThe CGL Quality Manual is a level one document in accordance with the ISO 13485:2003\\nInternational Standard and the cGMP-QSR. This manual defines an outline structure of the QMS\\nand its processes and serves as a direct reference for implementation and maintenance of the\\nQMS. The Quality Manual insures that all processes, work instructions and documentation satisfy\\nthe specified requirements of the customer and the ISO 13485:2003 International Standards and\\nthe cGMP-QSR. The Management Representative is responsible for establishing, implementing\\nand maintaining the QMS that is defined and documented in this Quality Manual.\\n      Documentation Requirements\\n      General\\n      Quality Manual\\nThe CGL QMS is defined, implemented and supported through a structure of procedural\\ndocumentation that is organized into various levels and categories. The levels are defined as\\nfollows;\\nLevel #\\nLEVEL #                                                                    DOCUMENTS\\n   1          The CG LABORATORIES Quality Manual,                          82005\\n   2          Procedures supporting the ISO 13485:2003 International       820XX & 820XXX\\n              Standards  and the cGMP-QSR (21 CFR, Part 820 for Medical\\n              Devices)\\n   3          Work instructions, test methods, process details, forms and  820XX-X &\\n              engineering drawings                                         820XXX-X\\nNote:       Records are an output of achieving results from tasks (can also be called\\n            documentation)\\nThe categories are characterized by a document identification system that utilizes a unique\\nnumber that relates to a primary focus area of the cGMP-QSR.\\nA complete description of the specification control procedures utilized can be found in\\nDocument and Data Control.\\nAll procedures referenced are consistent with the CGL Quality Policy CGL Management\\nRepresentative is committed to implementing and supporting this QMS and associated\\nprocedures effectively.\\nCertain military specifications may also be referenced in this manual if applicable.\\nControl of Documents- CGL Procedure 82040\\nAll documentation and data are controlled under the direction of the Process Owner of\\nDocument and Data Control and Records. Controlled documentation and data changes are\\nthe responsibility of key departmental personnel. The approval process can include both\\nelectronic or hard copy review and approval of the proposed change by affected personnel.\\nThe Management Representative has authorized certain CGL personnel to check and approve\\ncontrolled documentation. It is the responsibility of the key departmental personnel to insure\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"2Ln5qOVHzj5dSSwXzPYIUFoFix+yECaHYVltsNW9RVU=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_4":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_4\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\nDocument No.:       82005         Revision:    M         Page:        4       of       27\\n Title:              Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nthat the revised documents replace obsolete documents and are readily available for general\\naccess.\\nThe QMS documentation will continually reflect the size and complexity of the CGL\\norganization.\\nControl of Records- CGL Procedure 820180\\nCGL has established a procedure that details the control of quality records including their\\nidentification, collection, indexing, access, filing, storage, maintenance and disposition. The\\npurpose of these records is to demonstrate conformance to the specified requirements of our\\nQMS and therefore must be legible, retrievable and preserved. Retention times for each record\\nhave been established and recorded per the applicable procedure. As a minimum, all quality\\nrecords are retained for a period of ten (10) years. Supplier assessment records are also retained\\nand are available for customer review. Additional records which are retained as required\\ninclude management reviews, internal audits, corrective actions, supplier assessments,\\ncalibration, training, customer contracts, and verification, product inspection records (includes\\nrecords of nonconforming product), product identification and qualified process equipment\\nand personnel. All non-records such as procedures, forms, passed revisions or obsoleted\\ndocuments, etc. will be retained for the life of the company.\\nAs 21 CFR, Part 820 Subpart M mandates that the following records be maintained:\\nDHF   Design History File\\nDMR   Device Master Record\\nDHR   Device History Record\\nQSR   Quality System Record\\nComplaint Files (see section 7.2.3, this manual)\\nManagement Responsibility\\nManagement Commitment\\nThe CGL Management Representative is responsible for:\\n      Providing resources to implement and maintain a QMS that meets or exceeds the\\n      requirements of the ISO 13485: 2003 International Standard(s)\\n      Communicating the importance of meeting customer as well as statutory and regulatory\\n      requirements\\n      Ensuring the pursuit of continual improvement\\n      Ensuring the pursuit of established CGL Quality Policy.\\n      Ensuring the pursuit of established CGL Quality Objectives\\n      Attending management reviews as outlined in this manual\\n      The responsibility for insuring the implementation and maintenance of the QMS and that\\n      it meets or exceeds the requirements of the ISO 13485:2003 Standard rests with the CGL\\n      Management Representative.\\nCustomer Focus CGL Procedure 82020-11\\nThe CGL Management Representative meets or exceeds Customer Satisfaction by:\\n      Review and approval of customer contracts.\\n      Establishment of and adherence to customer service policies.\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"a1ZvYlGeyQvz2oR1WXfTL+7kclTKsoQFpxyh61j+zFI=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_5":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_5\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                              CG LABORATORIES, Inc. (CGL)\\n Document No.:         82005          Revision:      M          Page:         5         of       27\\n Title:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n       Resolution of differences between quotation and contract.\\n       Assurance that CGL can meet the customer contract requirements.\\nQuality Policy CGL Procedure 82020-1\\nThe C.G. Laboratories, Inc. objective is to offer Service and Guidance that shall meet customer requirements while\\nstriving to exceed customer expectations.\\nTo help achieve our ongoing commitment of customer fulfillment and confidence, the Management and staff of\\nC.G. Laboratories, Inc. are committed to complying with the requirements of ISO 13485:2003. The culture within\\nour company is built around our Never Stop dynamic which encompasses:\\n              Guidance through every process\\n              Beneficial Supplier Relationships\\n              Impeccable Product Quality\\n              Competitive Pricing\\n              Reasonable Lead-time\\n              On-time Delivery\\n              Cycle Time Reduction\\n              Cost Reduction\\n              Customer Satisfaction\\nThrough our Quality Management System, we monitor our own performance, set and monitor objectives,\\nmeasure the satisfaction of our clients, and strive to maintain a clear company-wide focus on excellence.\\nC.G. Laboratories, Inc……. where Service and Guidance Never Stops.\\nThe Quality Policy has been established with the pursuit for continual improvement of the QMS\\nas the focal point. This policy provided and continually provides the structure for the\\nestablishment and review of the CG LABORATORIES’ Quality Objectives.\\nBusiness and Quality Objectives\\n   Quality Objectives\\n       Preventive maintenance\\n           Late preventive Maintenance numbers are not trending upwards three quarters in a row\\n       Calibration\\n           Late calibration numbers are not trending three upwards quarters in a row\\n       Laboratory Department\\n           Laboratory Testing at least 95% for on-time reporting\\n              N/Cs, CAPAs, & complaints in OPEN status are not trending upwards 3 QTRs in a row\\n           N/Cs, CAPAs, & complaints issued are not trending upwards 3 QTRs in a row\\n           Complaints with a Severity of 9 or greater will be trended\\n       Packaging Department\\n           At least 90% on-time delivery\\n              N/Cs, CAPAs, & complaints in OPEN status are not trending upwards 3 QTRs in a row\\n           N/Cs, CAPAs, & complaints issued are not trending upwards 3 QTRs in a row\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"lIZk1N4Zv40b3A2zAmGDLjDyezxtj3exiDcmqt7yhCo=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_6":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_6\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                                 CG LABORATORIES, Inc. (CGL)\\n Document No.:            82005           Revision:        M           Page:           6         of         27\\n Title:                    Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n            Complaints with a Severity of 9 or greater will be trended\\n        Decontamination Department\\n                N/Cs, CAPAs, & complaints in OPEN status are not trending upwards 3 QTRs in a row\\n            N/Cs, CAPAs, & complaints issued are not trending upwards 3 QTRs in a row\\n            Complaints with a Severity of 9 or greater will be trended\\n            Decon- I/Misc 1\\n                At least 90% with 1-3 day TAT\\n                Less than 9% with 4-5 day TAT\\n                Less than 1% with 5+ day TAT\\n            Decon-II/ Misc 2\\n                Same unless specified below\\n                Product discards >95% 1-5 TAT, <5% 5+ TAT\\n                Bier Vessel catheter decontamination >95% 1-5 TAT, <5% 5+ TAT\\n                Medical Device trays >95% 1-5 TAT, <5% 5+ TAT\\nHandling audits anytime and constant cleanliness and organization are hallmarks for meeting the needs of our\\ncustomers and creating an enjoyable workplace.  If quality system items are an ongoing process instead of doing\\nthese quality items all at one time, then the workplace will be less stressful and quality will increase. This creates\\nan atmosphere that is proactive and quality-driven.\\nQMS planning activities at least include identifying activities and resources needed to establish and improve the\\nquality system itself. In fact, this requirement is met through completion of other activities required by the\\nstandard:\\nCG Laboratories plans to achieve the quality objectives and ensure continual improvement through the\\nmanagement review process. Outputs of quality planning can at least include:\\n        the quality system itself (i.e. the quality manual and associated procedures)\\n        resources for establishing, maintaining and improving the quality system\\nQMS planning at CG Laboratories applies to achieving quality objectives, but also to organizational change. Changes\\nin the CG Laboratory’s organization are planned in order to minimize the risk of negative effects on quality of\\nproduct and/or service. This is accomplished through a strategic planning process. Changes and their impact on\\nthe CG Laboratory organization and the quality system is an agenda item for every management review meeting\\nand certain QRB meetings. The results of management reviews are in the form of specific actions, ensuring that\\nimprovements are made in products/services and processes/systems, and that resource needs are identified.\\nManagement review outputs at CG Laboratories will set the direction for the future (i.e. new/revised policy can be\\nissued, improvement objectives can be established, and/or specific improvement initiatives can be approved).\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"nTu98s1aqLCGLy7mF81ARmjer2sMV5ZVtZil5rxiI60=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_7":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_7\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n Document No.:        82005         Revision:     M         Page:        7        of       27\\n Title:                Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n                                            Guidance\\n                                 Cost                      Supplier\\n                               reduction                 Relationships\\n                         Cycle Time          Customer         Product\\n                         Reduction          Satisfaction      Quality\\n                                On-time\\n                                delivery                 Competitive\\n                                                           Pricing\\n                                            Reasonable\\n                                             Lead-time\\nQuality Management System Planning CGL Procedure 82020-9\\nThis Quality Manual and all supporting procedures will be referred to as the Quality Plan. The\\nManagement Representative will define planning and implementation. All Quality Manual\\nelements and referenced level II procedural documentation are means for insuring that\\nproducts and processes are in conformance to ISO 13485:2003 International Standards, the\\ncGMP-QSR and customer specified requirements.\\nThe preparation of the plan shall be the Management Representative and those process\\nowners affected by these standards and requirements. This plan will be maintained in\\nconjunction with the management review meetings.\\nThe Quality Manual is an overview of the CGL Quality System and describes our conformance to\\nthese standards and requirements. It is the responsibility of the CGL Management\\nRepresentative to maintain this manual as necessary.\\nThe QMS is a formally documented process of planned activities established to provide\\nevidence of compliance to, ISO 13485, cGMP-QSR, contractual specifications, codes,\\nstandards, military specifications, drawings, Quality Policy and Quality Objectives.\\nAll of these activities are governed by procedures, written instructions supported by records of\\ntraining and the successful compliance of products and processes.\\nTypically, QMS output planning would be in the form of the following:\\n       the quality manual\\n       operating procedures\\n       work instructions\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"5pU3KtgFvIoHi0BS7g2cbBanmg34jO8uYgo1CtwT4A0=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_8":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_8\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005       Revision:    M         Page:       8        of      27\\nTitle:                Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n        flow charts\\n        process routings\\n        quality plans\\n Planning for resources can involve:\\n        personnel performing the verification activities\\n        personnel managing and performing the work\\n        sufficient time to do the work and verification\\n        identification of training needs\\n        obtaining appropriate equipment\\n        when applicable, development of documented procedures\\n        means of recording and accessing records\\n Considerations in the quality planning process may include the following:\\n        needs and expectations of the customers\\n        performance of the products\\n        performance operational processes\\n        learning from previous experiences\\n        risk identification and management (as well as analysis)\\n The Management Representative will control the planning, changes and implementation, of\\n procedures along with the documentation that will insure compliance to the Quality Objectives.\\n When changes are made to the QMS, care will be taken to insure integrity of the system.\\n The identification of controls and equipment needed to insure conformance to customer\\n requirements is the responsibility of the organizations or departments assigned to the immediate\\n task in conjunction with the appropriate Quality Systems’ Process Owners.\\n Planning Flow\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"4WauzTZ+Ve7jxXdR5OqprOcdNvcNJackqJJMkZxBT1A=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_9":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_9\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                              CG LABORATORIES, Inc. (CGL)\\n Document No.:         82005          Revision:       M         Page:           9        of       27\\n Title:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n                                      Obtain order\\n                                     Existing Process/        YES         Execute order\\n                                     Existing procedures?                 according to CGL\\n                                                                          procedures.\\n                                          NO                                □  Decontaminate\\n                                                                            □  Package\\n                                      Planning                              □  Test\\n                                      □  Validation\\n                                      □  Risk\\n                                      □  Safety\\n                                      □  Resources                           Document\\n                                      □  Equipment\\n                                      □  Pricing                               Activities\\n                                      Develop                              Documentation\\n                                      procedures and                            Review\\n                                      Forms\\n                                                                             Release of\\n                                      Train                                     Service\\nResponsibility, Authority and Communication\\nResponsibility and Authority\\nThe QMS Management Representative is responsible for insuring that the QMS is implemented\\nand maintained and that it meets or exceeds the requirements of the ISO\\n13485:2003International Standards and 21 CFR, Part 820 and achieves CGL Quality Policy and\\nQuality Objectives.\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"OU2h2MEGpHOJij4pI7NoKFqFXpoUprBqPYJsJpWRCgE=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_10":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_10\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                                      CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        10       of       27\\n Title:                               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nManagement Representative\\nThe GM of CG LABORATORIES is the Management Representative. The Management\\nRepresentative will inform top Management of:\\n      QMS performance\\n      state of the QMS\\n      the need for improvement (as needed)\\nThrough ongoing review of Quality Objectives, Customer Satisfaction monitoring and analysis,\\nthe Management Representative will promote customer requirements awareness throughout\\nthe organization.\\nInternal Communication CGL Procedure 82005-2\\nThe CGL General Manager and Management Representative, are responsible for providing\\nresources to communicate, implement and maintain the QMS that meets or exceeds the\\nrequirements of the ISO 13485:2003International Standards and the cGMP-QSR, and achieves\\nour Quality Policy and Quality Objectives.\\nCommunication regarding the effectiveness of the QMS is enacted and documented.\\n                             Top\\n                          Management\\n                             Sales\\n            Service Core                  Customer\\n            Competency                    Service\\n  Q                                                   Internal\\n  QRB                                                  Audit\\n                                                        Team\\n                       Total Customer Satisfaction\\n                 Operations               Quality Systems\\n                            Manufacturing Core\\n                            Competency\\n                   Information Systems\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"Cm1ihZHp3CPbNNKXMD0daSjkuQJoE/6jlrrIgYc78qI=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_11":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_11\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\nDocument No.:       82005         Revision:    M         Page:       11       of       27\\n Title:              Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nManagement Review CGL Procedure 82020-5\\nGeneral\\nQuality System audits are performed regularly by either internal resources or external sources to\\nprovide management with feedback and to insure its continuing suitability, adequacy and\\neffectiveness of the Quality System. Internal audits are used to evaluate the implementation\\nand the effectiveness of the Quality System and compliance of the Quality System against\\ncriteria based on ISO and cGMP-QSR. The Management Representative will review the Quality\\nSystem for effectiveness at a minimum of two times every twelve- (12) months. In addition,\\nmanagement will review performance relative to quality and other business metrics at the\\nManagement review meetings.\\nReview Input\\nDuring specified CGL QMS management reviews, the Management Representative will present\\nat least the following information on:\\n      audit results\\n      customer feedback\\n      process performance and product conformity\\n      status of preventive and corrective actions\\n      follow-up actions from previous management reviews\\n      changes that could affect the QMS and recommendations for improvement\\nOther considerations for information may be, but not limited to, the following:\\n      market place evaluation including the performance of competitors\\n      results of benchmarking activities\\n      performance of suppliers\\n      status of achieving the Quality Objectives\\n      changes in original assumptions, arising from new technologies, outputs of R & D, quality\\n      concepts, financial, social, environmental conditions and legislative or regulatory\\n      changes\\nThe review process may also revolve around the consideration of the following when\\napplicable:\\n      checking the relevance and the achievement of the existing Quality Policy and Quality\\n      Objectives\\n      updating policies and objectives as necessary\\n      Improvement plans for the overall effectiveness, adequacy and suitability of the QMS.\\n      measures to insure satisfaction of customers\\n      improvement to production processes, including reduction of scrap\\nReview Output\\nThe Management Representative will take actions, relevant to the applicable review input\\ncriteria, related to improvement of the QMS and its processes, improvement of product related\\nto customer requirements, and resource needs. These actions, at a minimum, will meet the\\nrequirements of the ISO 13485:2003International Standards and 21 CFR, Part 820.\\nRecords of management reviews will be maintained and may be in the form of, but not limited\\nto, one or more of the following:\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"kmfdKjIHTxM/RQeSOV3kTfDyKQtXL+aRjg9yFQ148ZA=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_12":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_12\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        12       of      27\\nTitle:                Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n        minutes potentially leading to CAPA initiatives\\n        agenda\\n        attendance list\\n Information contained in the records may include, but not limited to, one or more of the\\n following:\\n        who performed the review\\n        when the review occurred\\n        what was reviewed\\n        results of the review\\n        action items\\n        assignment of action items into the corrective and preventative action process (CAPA)\\n        status of previously assigned items\\n        conclusions\\n Resource Management\\n Provision of Resources\\n The Management Representative is responsible for identifying and making available the\\n necessary resources for performing Quality System activities that will meet or exceed the\\n requirements for products and service that will enhance customer satisfaction. Appropriate\\n training will be given to company personnel in their specific work functions and associated\\n Quality System activities.\\n Human Resources\\n General\\n When personnel are given assigned responsibilities that may have an effect on product quality,\\n the assigned responsibilities will be defined and be based on appropriate education, training,\\n skills and experience.\\n Note:  Where the expression “or equivalent” is used, as it relates to competence requirements, it\\n may be defined as one of the following:\\n        quantitative – an x number of years experience in lieu of formal education\\n        a determination made by the interviewer, Management Representative, or top\\n        management as a result of the interview process\\n Competence, Awareness and Training CGL Procedure 82025\\n The training of CGL personnel is focused on achieving the required skills necessary to supply\\n products and services that meet or exceed customer expectations.\\n The identification and approval of the required training is the responsibility of the Training\\n Process Owner, Supervisors, and potentially the Management Representative.\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"d2hX49SlMEfhygENWrM2exyJE5PJ5HDEjrS6a3Veaw4=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_13":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_13\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        13       of      27\\nTitle:                Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n The assigned responsibilities will be determined and documented and may be in the form of,\\n but not limited to, the following:\\n       job descriptions by function and responsibilities\\n       second-level procedures\\n       work instructions\\n       specifications\\n A variety of external and internal sources including procedural documentation, work\\n instructions, courses, seminars, conferences and individual study programs are utilized. Training\\n for subcontractors or temporary employees is always administered where appropriate.\\n The Document and Data Control Process Owner retains all training records of education,\\n experience, skills, training and qualifications including certifications, registrations and degrees\\n granted. Records can be in the form of:\\n       CGL training record\\n       signed application\\n       resume/CV\\n       copies of certificates\\n       diploma\\n       training attendance sheets\\n Personnel effectiveness training can be measured by, but not limited to, one or more of the\\n following:\\n       pre and post training testing\\n       internal auditing\\n       Monitoring of process performance in terms of defectives and responsibility for same.\\n Infrastructure\\n All buildings, workspaces, utilities, process equipment and associated supporting services which\\n directly affect quality, have been identified and planned to insure that conformity of product\\n requirements is achieved and maintained.\\n Work Environment\\n CG LABORATORIES employs a work environment that is suitable for all activities performed that\\n may affect product quality and ultimately customer satisfaction. Taken into consideration are\\n environmental conditions such as:\\n       lighting\\n       ergonomics\\n       work area cleanliness\\n       equipment orientation\\n       health, cleanliness and clothing of personnel\\n       spatial separation of product\\n       documented requirements for environmental conditions in assembly and component\\n       areas\\n       temporary employees follow the same rules as full and part-time employees and are\\n       trained accordingly\\n For calibration, consideration is given to environmental conditions such as:\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"YKDa17z6h0AOYRkk5wjGtD12NeRfukftYvgFIjLJ6ic=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_14":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_14\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005         Revision:    M         Page:        14       of       27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n       ambient temperature\\n       humidity\\n       vibration\\n       equipment proximity\\n Product Realization\\n Planning for Product Realization\\n This Quality Manual and all supporting procedures will be referred to as the Quality Plan. The\\n Management Representative will define planning and implementation\\n CGL documents all procedures and records for inspection and testing to verify that the\\n specified requirements have been met and to confirm achievement of process and product\\n conformity. Acceptance criteria for all activities as they relate to the verification, validation,\\n monitoring, inspection and testing of product, along with the related project(s) and contract(s),\\n have been determined with the quality objectives in mind.\\n As part of product realization, when a new product is introduced at CGL, or an existing product\\n is considered for modification, consideration will be given to the need for new processes and\\n resources or the modification of existing processes and resources to fit the needs of the specific\\n product. More preventive requirements considered are, but not limited to:\\n       criteria for workmanship\\n       environmental control\\n       personnel requirements\\n       contamination control\\n       buildings\\n       equipment\\n       automated processes\\n Risk Management:\\n ISO 13485 requires that organization establish documented requirements for risk management in\\n the product realization process. In the case of C.G. Laboratories, Inc. this has a direct impact on\\n process-related assessments. Directly, product-related risk management is the customer’s\\n responsibility unless contractually established for each unique situation. Risk management\\n includes risk assessment, risk analysis and risk reduction. Risk Assessment is identifying risks. Risk\\n Analysis is looking at the probability and severity of all hazardous situations. Risk reduction is\\n reduction, mitigation, elimination of risk as much as possible.\\n Risk management applies to quality management system processes in the case of C.G.\\n Laboratories Inc. and it also applies to the design of the device, manufacturing and supporting\\n services as delineated by C.G. Laboratories, Inc. customers in their formal requirements’\\n documentation. Risk management is such an important process that ISO 13485 requires risk\\n management is done in accordance with ISO 14971. The international standard for medical\\n device risk management is ISO 14971:2007 and EN ISO 14971:2012 (for customers requiring same\\n for CE Marking in Europe).\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"bZWDyESHUEmr1Ai3vFL2WY/ysXhXsllA28ZkrMuqPks=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_15":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_15\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        15       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nRisk Management provisions will be employed throughout these processes.\\nCustomer-Related Processes\\nDetermination of Requirements Related to the Product/ Service\\nIt is the joint responsibility of every employee to insure that, while interfacing with the customer,\\nthe product/service requirements are identified and documented, from conception to\\ncustomer receipt to the intended use of the product. Additionally, this joint responsibility\\nencompasses any statutory and regulatory requirements related to the product.\\nReview of Requirements relating to the Product/ Service\\nAll customer requirements reviews take place prior to order acceptance. An amendment to a\\ncontract is initiated using the same procedures followed when establishing the initial contract.\\nRecords of new and current contracts including amendments to those contracts are retained\\nand the full responsibility by and of the Process Owner for Records.\\nThe responsibility of reviewing customer requirements can be a combined or the sole effort of\\nthe Management Representative.\\nCustomer Communication\\nThe first point of customer contact as it relates to product information, inquiries, contracts or\\norder handling, including amendments, customer feedback and customer complaints will be\\nthe sales personnel or customer service for that department. Determination of inquiry\\nassignment will be as per CGL documented procedures.\\nComplaint files CGL Procedure 820100\\nThe CGL organization has made provisions for the following requirements:\\nComplaint files and procedures are established and maintained for receiving, reviewing, and\\nevaluating complaints by a formally designated unit. Such procedures ensure that:\\n      all complaints are processed in a uniform and timely manner;\\n      oral complaints are documented upon receipt; and\\n      Complaints are evaluated by QRB to determine whether the complaint represents an\\n      event, which is required to be reported to FDA, Medical Device Reporting.\\n      The QRB shall review and evaluate all complaints to determine whether an investigation\\n      is necessary. When no investigation takes place, the CGL shall maintain a record that\\n      includes the reason no investigation occurred and the name of the individual responsible\\n      for the decision not to investigate.\\n      Any complaint involving the possible failure of a device, labeling, or packaging to meet\\n      any of its specifications shall be reviewed, evaluated, and investigated, unless such\\n      investigation has already been performed for a similar complaint and another\\n      investigation is not necessary.\\n      Any complaint that represents an event which must be reported to FDA under part 803 or\\n      804, shall be promptly reviewed, evaluated, and investigated by a designated\\n      individual(s) and will be maintained in a separate portion of the complaint files or\\n      otherwise clearly identified. In addition to the information required by Sec. 820.198(e) of\\n      cGMP Title 21 CFR part 820, records of investigation under this paragraph will include a\\n      determination of:\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"01orx0SuNjvDUyCzCGf9q3Q9Fa26qSSZvIRwjZlqGA0=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_16":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_16\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        16       of      27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n          o  whether the device failed to meet specifications\\n          o  whether the device was being used for treatment or diagnosis; and\\n          o  the relationship, if any, of the device to the reported incident or adverse event\\nWhen an investigation takes place under this section, the formally designated unit for handling\\ncomplaints will maintain a record of the investigation. The record of investigation will include,\\nbut not limited to:\\n      the name of the device;\\n      the date the complaint was received;\\n      any device identification(s) and control number(s) used;\\n      the name, address, and phone number of the complainant;\\n      the nature and details of the complaint;\\n      the dates and results of the investigation;\\n      any corrective action taken; and\\n      any reply to the complainant\\n      If, in the event a the formally designated complaint unit is located at a site separate from\\n      the CGL manufacturing establishment, the investigated complaint(s) and the record(s) of\\n      investigation will be reasonably accessible to the manufacturing establishment.\\n      If, in the event a the formally designated complaint unit is located outside of the United\\n      States, required records will be reasonably accessible in the United States at one of the\\n      following locations:\\n          o  in the United States where the manufacturer's records are regularly kept; or\\n          o  the location of the initial distributor\\nPurchasing\\nPurchasing Process CGL Procedure 82050\\nPurchasing activities include selection, evaluation and assessment of suppliers, contractors,\\nconsultants, etc., i.e. product and/or service procurement and verification that purchased\\nproduct and/or service conforms to specified requirements. This applies to all inventory items,\\nsupplies and capital equipment for CGL.\\nCGL evaluates and selects subcontractors based on their ability to meet CGL Quality, Cost and\\nDelivery requirements.\\nContinued use of a supplier, contractor and/or consultant will depend on product or service\\nquality, delivery and cost.\\nQuality records for all suppliers supplying inventory materials are maintained.\\nCGL maintains supplier evaluation categories. Suppliers’ categories are updated by QRB, when\\nproduct or equipment is supplied to CGL.\\nPurchasing Information\\nCGL purchase orders and/or included documentation contain a clear definition and/or\\ndescription of all requirements. This includes:\\n      price and delivery\\n      part number or model number\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"tx9yHl95ys5XSxHiCJMMSY0WfkCWyNJkylo7jaRaUGM=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_17":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_17\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005         Revision:    M         Page:        17       of       27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n       material description\\n       specifications and drawings (revisions, thereof)\\n       inspection instructions or specific requirements\\n        any other technical or contractual requirements that may apply\\n Purchasing documentation will include, where possible, an agreement that suppliers,\\n contractors, and consultants agree to notify and obtain explicit written approval from CG\\n LABORATORIES of any changes in the product or service so that it may be determined whether\\n the changes affect the quality of a finished device and / or service performed.\\n The Purchasing Process Owner is responsible for reviewing and approving purchasing\\n documents for accuracy of specified requirements prior to release.\\n Verification of Purchased Product\\n Where specified in the contract, CGL has the authority to verify at the supplier’s facility, that\\n purchased product conforms to specified requirements.\\n Incoming product will be inspected by receiving inspection. Verification of conformance to\\n specified requirements is in accordance with CGL documented procedures. Retention of\\n verification records will follow the section for Records of this document.\\n Suppliers, subcontractors and consultants will assure quality of product and/or service through a\\n quality system that meets CGL quality requirements. Evidence of compliance to these\\n requirements will be determined through the Certificate of Conformance and/or Certificate of\\n Analysis, audits as necessary and continued monitoring of certain aspects of quality, cost, and\\n schedule.\\n Production and Service Provision\\n Control of Production and Service Provision CGL Procedure 82070\\n All production processes, which directly affect quality, have been identified and planned to\\n insure that these processes are carried out under controlled conditions.\\n Included with needed process controls are:\\n       documented instructions, standard operating procedures (SOP's), and methods that\\n       define and control the manner of production\\n       monitoring and control of process parameters and component and device\\n       characteristics during production\\n       workmanship criteria\\n       compliance with specified reference standards or codes\\n       the approval of processes and process equipment\\n As product is prepared for delivery, manual or electronic systems provide current shipping and\\n routing information. With implemented and defined labeling and packaging operations,\\n shipping labels and documents are generated electronically utilizing bar code technology, if\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"r5sFvFWbJ+90IL2COULgJ/gtshucMNRJz/bFFc9xp1g=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_18":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_18\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:     M         Page:        18       of      27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nspecified by the customer, to prevent errors. The customer determines the transportation type\\nand site destination of product via the desired carrier.\\nCGL guarantees its devices according to the terms and conditions of its order\\nacknowledgement and invoice documents.\\nThe Quality System’s Process Owner is responsible for resolving all quality related customer\\ncomplaints.\\nCustomer quality inquiries are reviewed by the GM. Appropriate action is taken by the\\ndepartment supervisor to evaluate and resolve the customer’s problem. Quality Systems may\\nbe contacted for customer consultation. CGL Quality Systems may be called on for evaluation\\nand support.\\nQuality Systems may generate return Material Authorization (RMA) numbers. Purchasing can\\ninitiate credit memos for valid return of goods, price corrections or other customer service\\nrelated reasons. The General Manager is responsible for final approval of customer credits and\\ngenerates the credit document.\\nDocument and Data Control maintains records of all quality related customer problems as well\\nas records of non-quality related customer problems in a controlled file. Accounting retains all\\ncredit memos on file.\\nValidation of Processes for Production and Service Provision\\nQualified operators will enact the validation of any process where deficiencies may only be\\napparent after the product is in use. The validation process will include (as applicable), but not\\nlimited to:\\n       manufacturing orders, product drawings, process specifications, procedures and work\\n       instructions that have defined workmanship criteria that is subject to review and approval\\n       the master validation plans for process, product and software\\n       specific methods and procedures such as selection and control of equipment used in the\\n       manufacture of product, which is accomplished through calibration, maintenance and\\n       preventive maintenance programs to insure capability and product quality. Provisions for\\n       controlled environments are available when necessary\\n       qualification records for processes and key personnel, as necessary\\nWhen changes or process deviations occur, CGL Process Owner of Validation reviews and\\nevaluates the process and performs revalidation where appropriate and documents these\\nactivities. The master validation plan(s) for process, product and / or software are the drivers for\\nthe validation efforts at CG LABORATORIES.\\nExclusion\\nDue to the nature of CGL Products and their end use by the customer, exclusion is claimed to\\nthe Installation and Service Provision of this section. CGL products are not installed and/or\\nserviceable, but rather replaceable.\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"ylxWhPyOajP03cTqxykW1DK9ZJytvqgmzspLfKldm58=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_19":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_19\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        19       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nIdentification and Traceability CGL Procedure 82060\\nProduct identification and traceability is facilitated manually or using validated software and\\nmaintained at all stages, from receiving to delivery into the marketplace. The means by which\\nproduct is identified are manufacturing orders, move documentation, identification tags and/or\\nlabels. Product status is also identified with respect to monitoring and measurement\\nrequirements. Subassembly parts, assemblies or final products that have passed required tests or\\ninspection, and in the process of being moved to the next production phase or final disposition\\nare identified to indicate inspection status. One or more of the following methods may be used:\\n      tags\\n      stamps\\n      labels\\n      inspection and test records\\n      move documentation\\n      process worksheets\\n      corrective action/rejection reports and/or status\\nCGL has established and maintains procedures to insure that Device History Records (DHR) for\\neach batch, lot, or unit are maintained and verified to demonstrate that the device is\\nmanufactured in accordance with the DMR and the requirements of this section.\\nManually derived and administered documentation, as it relates to inspection and test results of\\nproduct, are maintained for the release of conforming product. Inspection records are\\nmaintained by Document and Data Control to show that the product has passed all defined\\nacceptance criteria.\\nAll devices will be traceable to the supplier lot. All products will be identified with an inspection\\nand item number.\\nTo show that product has been inspected and/or tested, Document and Data Control\\nmaintains the records that provide this evidence. These records indicate whether product\\nconforms to established quality standards. Where the product fails to pass any inspection\\nand/or test, the procedures for nonconforming product shall apply. Records identify the\\ninspection authority responsible for the release of the product.\\nCustomer Property\\nWhen required by the contract, the customer may furnish material to CGL for specific\\nproduction purposes.\\nSuch materials are subjected to the same control measures as subcontractor and in-house\\nproduced product. This includes receiving inspection for verification of conformance, material\\nidentification and traceability, controlled and protected stock or storage, manufacturing\\ncontrol and final or completed product inspection.\\nRecords detailing the control of customer-supplied product per the above-described areas are\\navailable for customer review.\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"c8QPaPuYzbePsKGyu/S/8xpXT0Omhc35QPJGf3AXy18=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_20":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_20\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:     M        Page:        20        of      27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nWith the identification of any nonconformance during the inspection and handling of these\\nmaterials, immediate notification of the customer takes place for purposes of product lot\\ndisposition. CGL has and maintains a record of such occurrences.\\nPreservation of Product\\nCGL has established procedures for handling, storage, packaging, preservation and delivery of\\nproduct.\\nProducts that require special handling have detailed requirements as part of the customer\\nspecification, manufacturing order or engineering drawing. In the absence of a specified\\nrequirement, the utilization of standard operating procedures will become the default to\\nmaintain product integrity.\\nThe use of controlled and secure stock locations is to prevent product damage or deterioration\\nand to maintain lot control. Product issued to the production floor or for customer delivery is\\nstored separately and handled by warehousing and manufacturing personnel. CGL products\\nare handled on a first in, first out basis. In-process or final product that require non-standard\\nstorage to prolong or protect product shelf life and general integrity, has such requirements\\nspecified per the appropriate product documentation. Where appropriate, an assessment of\\nproduct shelf life will be done.\\nAll standard in process and final product packaging is designed to protect the material from\\ndamage or deterioration and maintain lot control. Non-standard packaging or marking\\nrequirements as specified per customer specifications or contracts are controlled by\\nappropriate procedures.\\nAppropriate and necessary methods and practices are utilized in the preservation and\\nsegregation of product\\nControl of Inspection, Measuring and Test Equipment CGL Procedure 82072\\nCGL has established documented procedures, with guidance from ISO 17025, for controlling\\nthe calibration of all test and measurement instrumentation. This includes gages, instruments,\\nsensors, test equipment and related software used in the development, production, installation\\nand servicing of product. The objective of our calibration program is to provide a system that\\nassures conformance to specified requirements, calibrated standards and confidence in\\nmeasurement data.\\nQuality Systems determines the pertinent measurements and the degree of accuracy required\\nby appropriate inspection and measuring test equipment.\\nStandards and equipment used for calibration are traceable to N.I.S.T. Measuring and test\\nequipment is tagged as follows, indicating calibration status:\\n       Calibration date\\n       Next calibration date\\n       Serial and asset numbers (original manufacturer S/N if applicable and an CGL asset #)\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"gjf7wuHcBUd2H8mBgWPhyoKVVTpmLdowsy3M1wWw/fU=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_21":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_21\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005        Revision:     M         Page:        21       of      27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n       Calibrated by\\n Calibration of inspection, measuring and test equipment, including details of equipment type,\\n unique identification, location, frequency of checks, check method, acceptance criteria and\\n the action to be taken when results are unsatisfactory are described in Calibration System\\n Requirements delineated for each unique and / or particular measuring device.\\n CGL maintains calibration records of all inspection, measuring and test equipment. These\\n include records of equipment calibrated on or off site.\\n When out of calibration conditions are detected, inspection, measuring and test equipment is\\n re-calibrated, repaired or replaced and affected product re-tested per CGL procedures.\\n Environmental conditions suitable for calibration, inspection and measurement are defined in\\n CGL procedures.\\n To insure that accuracy and fitness for use is maintained, inspection test and measurement\\n equipment is located in secured areas and handled by authorized personnel.\\n Inspection measuring and test facilities, including both test hardware and test software are\\n protected from adjustments that would invalidate the calibration setting per the CGL\\n procedure.\\n Measurement, Analysis and Improvement\\n General\\n In an effort to meet the specified requirements of the International Standards and 21 CFR, Part\\n 820, CGL has planned, implemented and performs the measurement and analysis activities to\\n assure product conformity and efforts toward continual improvement of the QMS.\\n The use of statistical methods, among other techniques, is beneficial to establish, control and\\n confirm desired process and product characteristics. Statistical tools such as histograms, process\\n control charts, trend analysis and / or praeto charts, etc. may be utilized as appropriate in the\\n following areas:\\n       Quality Systems\\n       Manufacturing\\n       Internal audit results assessment\\n       Product performance assessment\\n       Supplier Performance\\n       Complaints and Adverse Events\\n Procedures describing applicable statistical techniques are contained in the production,\\n inspection and design review procedures.\\n Monitoring and Measuring\\n Customer Feedback and Satisfaction\\n CGL will assume a proactive role in the determining the level of customer satisfaction and/or\\n dissatisfaction. This will be accomplished by measuring these levels and monitoring whether the\\n customers needs are being met. The acquisition of data will be centered on areas that are\\n important to our customer base and may come from, but not limited to, methods such as:\\n focus groups\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"4X44Ue2w5o1UM5RyCopu1LjD+qFySrKLm2iA3ZNxjUs=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_22":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_22\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                             CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005         Revision:    M         Page:        22       of       27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n        customer visits – regional sales managers, key account managers, company\\n        representatives, quality system personnel\\n        customer satisfaction surveys\\n        customer complaints\\n        direct communication with customers – account managers, quality system personnel\\n        customer organization reports\\n        media reports\\n        sector studies\\n Internal Audit CGL Procedure 82022\\n The QMS is monitored for, ISO 13485:2003 and 21 CFR, Part 820 compliance by an internal audit\\n process and cross-functional audit team (seeks guidance from ISO 19011). This process includes\\n audits designed to evaluate all systems, policies, procedures, processes and products within the\\n organization that affect product quality or service.\\n The audit process covers quality system audits in compliance with IS0 and cGMP-QSR Quality\\n System requirements. This includes audits of procedures and work instructions as well.\\n Internal audits are scheduled and conducted based on previous audit results and the status\\n and importance of the activity. Personnel independent of those audits having direct\\n responsibility for the audited activity conduct them.\\n Audit results including required improvements become a matter of record and then forwarded\\n to the management personnel having responsibility for the area audited.\\n Specific management personnel responsible for the area under audit will take the necessary\\n corrective action without undue delay to eliminate the nonconformities and report the\\n verification results.\\n Follow-up audit activities are performed to verify the results and effectiveness of the corrective\\n action taken.\\n The internal audit process results are reviewed at least four times every twelve (12) months\\n during management review. This review is an integral part of the input and output to\\n management review activities and general QMS improvements.\\n Monitoring and Measuring of Processes\\n In determining if a CGL process has the ability to satisfy its intended use / purpose, which\\n includes active implantable devices and / or one-use devices, consideration may be given to\\n all or part of the following attributes:\\n        repeatability\\n        timeliness in a process or personnel performing a task\\n        the competency level of personnel performing tasks\\n        process constraints related to equipment and / or material availability\\n        revalidation opportunities\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"yQPt1z5zRmo02av2J9wGqbRwf4Vw+X+4grfzserw2Ks=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_23":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_23\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                            CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005        Revision:     M         Page:       23       of       27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n Where needed, essential process controls and validation are:\\n       documented instructions, standard operating procedures (SOP's), and methods that\\n       define and control the manner of production;\\n       monitoring and control of process parameters and component and device\\n       characteristics during production;\\n       compliance with specified reference standards or codes;\\n       the approval of processes and process equipment; and\\n       criteria for workmanship that shall be expressed in documented standards or by means of\\n       identified and approved representative samples.\\n Depending on product type, the use of suitable methods for monitoring, and if applicable, the\\n measuring of the QMS processes may include, but not limited to, one or more of the following:\\n       measuring reaction time\\n       cycle time\\n       measurable aspects of dependability\\n       efficiency of the process\\n       waste reduction\\n       cost allocation and reduction\\n When planned results are not achieved when using the decided methods, correction will be\\n made and corrective action will be taken.\\n Monitoring and Measuring of Product\\n Incoming Inspection – incoming product and raw material requires inspection, testing, or\\n otherwise verified as conforming to specified requirements prior to release. Verification of\\n conformance to specified requirements is in accordance with the CGL quality plan and\\n documented procedures.\\n Suppliers, subcontractors and consultants will assure quality of product and/or service through a\\n quality system that meets or exceeds CGL quality requirements. Evidence of compliance to\\n these requirements will be determined through the Approved Supplier process (list).\\n There will be no use, processing or release of incoming product until its verification as\\n conforming to established requirements by means of inspection is complete.\\n Sampling Plans – reference to ANSI Z1.4 or Z 1.9 will be made for sampling plans.\\n First Article Inspection – is the submission of product to inspection prior to the start of any\\n manufacturing order to confirm process control and product conformance.   The start of a\\n manufacturing order will not be granted until approval of first piece inspection is granted.\\n In-Process Inspection - confirms in-process manufacturing control by periodic operator on-line\\n inspection and submittal of product for final in-process inspection. Recording of these results is\\n limited to final in-process inspection only.\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"A3hKm8ahkG2cUbKMDvZBuaN62KlDsPwH58GE2EoAc2w=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_24":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_24\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        24       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nFinal Inspection – confirms final assembly control by testing in accordance with the CGL Quality\\nPlan under the guidelines of the inspection process and DHR review/disposition. Finished\\nproduct is not shipped pending review of documentation requirements as designated by 21\\nCFR, Part 820.80.\\nNote: Acceptance status is documented for all inspections.\\nInspection records provide evidence that product verification as it relates to in-house, customer\\nand regulatory requirements and that testing was completed. These records indicate whether\\nproduct conforms to established quality standards and CGL specifications. Where the product\\nfails to pass any conformity requirements and/or test, the procedures for nonconforming\\nproduct shall apply. Records identify the inspection authority responsible for the release of the\\nproduct.\\nWhen planned results are not achieved when using the decided methods, correction will be\\nmade and corrective action will be taken.\\nOther methods of measuring and/or monitoring not mentioned above may include, but not\\nlimited to, the following:\\n      product audits monitoring specified activities\\n      operator in-process inspection\\n      automated inspection and test\\n      monitoring in-process instrumentation that controls processes or testing samples taken at\\n      defined locations and intervals\\n      fixed inspection stations at intervals throughout the process\\nControl of Nonconforming Product 82090-2\\nThis section covers nonconforming product from suppliers, in-process and final product with the\\nfollowing criteria and/or noteworthy points:\\n      that does not conform to specified requirements\\n      nonconforming issues address the identification, documentation, evaluation,\\n      segregation, and disposition of nonconforming product, including a determination of the\\n      need for an investigation and notification of the persons or organizations responsible for\\n      the nonconformance\\n      nonconformities are reviewed and achieve disposition and are documented\\n      responsibility for review and the authority for the disposition of nonconforming product is\\n      defined\\n      documentation includes the justification for use of nonconforming product and the\\n      signature of the individual(s) authorizing the use\\n      rework procedures exist and include retesting and reevaluation of the nonconforming\\n      product to insure that the product meets its current approved specifications; these\\n      activities are documented\\n      documentation within the DHR will apply to all medical devices\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"cFaPXimwr+r99srRXe0kBssxFau/+3kqflKFrUD0H+M=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_25":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_25\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        25       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nProcedures are implemented to insure that products that do not conform to specified\\nrequirements are prevented from unintended use. These procedures provide identification,\\ndocumentation, evaluation, segregation and disposition of nonconforming product.\\nCGL Quality Systems’ is responsible for the disposition of nonconforming product. Purchased in\\nprocess and final inspection components, assemblies and / or devices are subject to test and\\ninspection according to applicable procedures as documented in the applicable procedures.\\nDepartment Supervisors will identify and segregate nonconforming product for disposition by\\nthe Process Owner for Quality Systems. If nonconforming product is found during production\\nprocessing, a decision concerning product disposition is then made. Upon determination of\\nstatus, a rejection/corrective action request is issued and one of the following occurs:\\n      units are re-worked to meet the specified requirements\\n      units are accepted by concession with the customer\\n      units are reviewed for concessions with the customer\\n      units are rejected by using the concession tool (with the customer)\\n      units are rejected or scrapped by CGL\\nWhere required by the contract, the proposed use or repair of product that does not conform\\nto the specified requirements will be reported to the customer. Records are kept describing the\\nnonconformity which has been accepted, including any repairs for denoting the actual\\ncondition.\\nRe-inspection will occur for all repaired and/or re-worked product in accordance with\\napplicable procedures and specifications.\\nAnalysis of Data\\nIn an effort to drive improvement efforts within CGL, the data that is accumulated through\\ninternal monitoring of processes and other sources, which may include but not limited to:\\n      surveys\\n      internal evaluations\\n      customer focus surveys\\n      customer complaints and feedback\\n      marketing department input\\n      third party audits\\nThe data that is accumulated will be relevant to continual improvement as it relates to\\ncustomer satisfaction and/or dissatisfaction, conformance or customer requirements,\\ncharacteristics of processes, product and trends and suppliers.\\nImprovement and\\nContinual Improvement\\nIt is the intention of CGL that continual improvement to the QMS shall occur regularly and\\nfrequently, but not necessarily without interruption. When opportunities for improvement are\\nrealized, they will be prioritized focusing on the ones that will produce the greatest return on\\ninvestment. These activities will be delineated and facilitated via the Process Owner of Quality\\nSystems.\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"phIXP7BM4DAv/r8PbsuUZaq5AlHKPLvcIr4uG44nvGk=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_26":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_26\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        26       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nTo facilitate a well-rounded continual improvement effort, the focus will not be centered on the\\nnonconformance identified with the system, but rather inclusive of, and not necessarily\\nsimultaneously, the following areas:\\n      quality policy\\n      quality objectives\\n      analysis of data\\n      management reviews\\n      corrective and preventive actions\\n      internal audit results\\n      employee suggestions\\nCorrective Action CGL Procedure 820100\\nCGL has established documented procedures for the implementation of corrective action.\\nQuality Systems evaluates discrepant inspected product or process and determines lot\\ndisposition, effectiveness and corrective action, respectively. Procedures for corrective action\\ninclude, but not limited to:\\n      the effective handling of customer complaints and reports of product nonconformities\\n      investigation and documentation of the cause of nonconformities relating to product,\\n      process and the quality system)\\n      determination of the corrective action needed to eliminate the cause of\\n      nonconformities,\\n      application of controls to insure that effective corrective action is taken\\nManagement review sessions conducted in accordance with QMS will be used to evaluate the\\nneeds for corrective and preventive action through the analysis of various system measurement\\nresources and may include, but not limited to:\\n      customer return records\\n      customer product complaints\\n      supplier corrective actions\\n      corrective action reports that deal with detected nonconformities relating to products,\\n      processes and the QMS\\n      purchasing (supplier) history\\n      customer quality/delivery reports\\n      process control deviations\\nPreventive Action\\nCGL has established documented procedures for the implementation of preventive action.\\nProcedures for preventive action include, but not limited to:\\n   The use of information, such as processes and work instructions which affect product quality,\\n   concessions, audit results, quality records and customer complaints, to detect, analyze and\\n   eliminate potential causes of nonconformities.\\n   Determination of the steps needed to deal with any problems requiring preventive action,\\n   Initiation of preventive action and application of effective controls,\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"MSpA+4qB9zv9lMNbB//LwF0CDZXhJDncYxjijrBwMqU=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_27":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_27\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                           CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        27       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n   Insurance that relevant information on action taken is submitted for management review\\n   Sources of information that may be analyzed in order to detect and eliminate potential\\n   causes of nonconformities include, but not limited to:\\n      nonconformity records\\n      inspection and test records\\n      process monitoring results\\n      audit observations\\n      results of customer satisfaction surveys\\n      customer complaints/records\\n      regulatory authority or customer observations\\n      observations and reports by personnel\\n      sub-contractor problems\\nStatistical Techniques CGL Procedure 820250\\nCGL will establish and maintain procedures for identifying valid statistical techniques required for\\nestablishing, controlling and verifying the acceptability of process capability and product\\ncharacteristics. Sampling plans shall be written and base on ANSI Z 1.4 logic and rationale. CGL\\nwill make sure that these sampling methods are adequate for their intended use and ensure\\nthat when changes occur the sampling plans are reviewed and revised accordingly.    These\\nactivities shall be documented.\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"z/5V+w1LLZi27vP01yhtaGJdQYNob3weqSTz4vup1jY=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_1":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_1\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                              QUALITY AGREEMENT\\n                                      Between\\n                                        And\\n                                 C&G Laboratories\\n                               1410 Southtown Drive\\n                              Granbury, Texas 76048\\n                          Issue date:\\nRevision History\\nAmendment         Detail of Change                                          Date\\nn/a               Original issue\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"IvZj5JOObagxgN7HAcAOjctaNNZ+5Cn3PNRO5yHVDTk=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_2":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_2\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"QUALITY AGREEMENT APPROVALS:\\n(Quality Agreements between I sites require the approval of the site manager, QA and RA)\\nI Austin\\nQuality Assurance\\n Name                                             Title\\n Signature                                        Date\\nRegulatory Affairs\\n Name                                             Title\\n Signature                                        Date\\nSite / Plant Manager\\n Name                                             Title\\n Signature                                        Date\\nI LifeSciences Corporate Office\\nCorporate QA (if required)\\n N/A                                              N/A\\n Name                                             Title\\n N/A                                              N/A\\n Signature                                        Date\\n                                     Page 2 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"Vf1PlAsH4Gbxk0u+9PC2Y+eadBudvQ/0zVPXQ49/ojg=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_3":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_3\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"CG Labs (Granbury, Texas)\\nQuality Assurance\\n Name                                             Title\\n Signature                                        Date\\nRegulatory Affairs\\n Name                                             Title\\n Signature                                        Date\\nSite / Plant Manager\\n Name                                             Title\\n Signature                                        Date\\n                                     Page 3 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"z6g2DpW1yntwPeAV7Rm/viS3uYvt2gINoeA14mdWVlE=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_4":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_4\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"1.  PURPOSE\\n    The purpose of the Quality Agreement is to clearly outline key responsibilities for communication,\\n    controls, and quality assurance measures that must be established for both      I LifeSciences Austin and\\n    C&G Laboratories located at 1410 SouthTown Dr. Granbury Texas 76048. This Quality Agreement will\\n    ensure that products are manufactured according to agreed-upon specifications and Quality System\\n    requirements.\\n    C&G Labs is responsible for cleaning/ decontamination devices manufactured by          I LifeSciences and\\n    providing consultation services in matter of sterilization and cleaning of medical devices.\\n    This Quality Agreement is entered into and made effective upon the date of its signature by all\\n    approvers.\\n    Approval of this Quality Agreement will ensure that products are provided according to specifications\\n    and that products comply with applicable FDA Quality System Regulations, cGMPs, EN ISO 13485,\\n    the  Canadian  Medical  Device  Requirements   (CMDR),   the Medical  Directive (93/42/EEC           plus\\n    amendments), any other applicable regulations, product specifications and company policies and\\n    procedures as applicable.\\n2.  SCOPE\\n    This agreement is applicable to all products that are cleaned / decontaminated at C&G Labs. C& G\\n    labs Granbury facility is responsible for cleaning / decontamination of products that are returned from I\\n    customers (Surgeons, Hospitals, Surgery Centers, Distributors, and Global Distribution Centers etc.)\\n    Or from one of the I’s facility.\\n3.  QUALITY AGREEMENT REVIEW ANDMAINTENANCE\\n    It is the responsibility of the site Manager of QA (or delegate) to ensure that this agreement is reviewed\\n    annually. Modifications shall be made as required following the current change control procedure at the\\n    Site and approved by the same functions that signed the original agreement. Management at both\\n    facilities shall communicate any information in case of discrepancy, issues, changes related to the\\n    requirements described hereafter.\\n4.  RESPONSIBILITIES\\n    The Manager of Quality Assurance for        I LifeSciences Austin and the designated representative(s) at\\n    C&G labs at Texas site is responsible for ensuring that this Quality Agreement is properly executed.\\n5.  QA CONTACTS\\n    I Austin                                   C&G Labs\\n    Vishwas Sharma                                    Briana Monroe\\n    Sr Manager, Supplier Quality Management           Quality Assurance Manager\\n    +1-(512)-852-3945                                 +1-817-279-1945\\n    vishwas.sharma@Ilife.com                   bmonroe@cg-labs.com\\n6.  DEFINITIONS\\n    I site - refers to the I LifeSciences site who is the design control owner.\\n    Supplier - refers C&G laboratories Texas, that is providing the finished products\\n    Nonconforming product - refers to a product that does not fulfil of a specified requirement.\\n    Complaint  - refers to any written, electronic or oral communication that alleges deficiencies related to\\n    the identity, quality, durability, reliability, safety, efficiency, or performance of a device after its release\\n    for distribution.\\n                                         Page 4 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"69xXXE4dn3qZLoBf4EEtAh5mKxHQK1gPOEOeqJe+THw=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_5":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_5\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"    Recall -          refers to the removal or correction of a marketed product that the Competent Authority\\n    considers to be non-conforming with standards and against which the agency could initiate actions.\\n7.  MANAGEMENT RESPONSIBILITY\\n    The Vice President/Quality Leader at Supplier and    I are responsible for quality planning and assuring\\n    that resources are dedicated to achieve requirements of regulatory agencies and customers.\\n8.  QUALITY AUDITS\\n    Both parties are responsible for having an internal and supplier audit program in place. Based on the\\n    existing EU Medical Device Directive (93/42/EEC, as amended), Notified Bodies have the authority to\\n    perform unannounced audits. To verify day-to-day compliance to legal requirements,   I’s Notified Bodies\\n    may determine it is necessary to visit the site of a critical component or finished device manufacturer\\n    without prior notice. If you choose to deny access to a Notified Body’s audit team, please notify      I\\n    immediately. Your cooperation, if an unannounced visit should occur, it sincerely appreciated. Supplier\\n    shall allow the I Notified Body and the Competent Authority of      I to examine technical documentation\\n    held by C&G labs site for products specifically supplied to I.\\n9.  QUALITY SYSTEM /REGULATORY COMPLIANCE\\n    C&G labs shall notify   I within twenty-four (24) hours of receipt of contact from the FDA, ISO Notified\\n    Body, or any other regulatory agency if such entity contacts C&G labs to investigate or inspect its\\n    facilities with respect to the Products or manufacturing records of the Products provided to I and notify\\n    I of any applicable findings or corrective actions related to their Product. C&G labs will immediately\\n    notify I of any regulatory action taken against C&G labs that would affect product availability or bring\\n    into question the quality and safety of the Products sourced by I.\\n    I shall notify C&G labs within twenty-four (24) hours of any FDA, ISO or any other regulatory agency\\n    audit of I that is related to Products cleaned at C&G labs     site or services provided by C&G labs and\\n    notify C&G labs of any applicable findings or corrective actions related to the Products.   In addition,\\n    where a response or corrective action and preventive action are required,    I will submit a response to\\n    C&G labs for review prior to submission, as applicable.\\n10. Record Retention\\n    C&G labs shall retain all documentation generated during the manufacturing process as required by  I’s\\n    Standard Operating Procedures (hereinafter “SOPs”) and based on the expected life of the device, but\\n    no less than five (5) years from the date of release of the device for commercial distribution.  I shall\\n    retain      distribution     documentation        in      accordance        with      I’s          SOPs.\\n11. AGREEMENT MAINTENANCE\\n    This Quality Agreement may be reviewed as mutually agreed upon by the Parties. No amendment,\\n    modification or alteration to this Quality Agreement shall bind either Party unless made in writing and\\n    approved by both Parties.\\n    This Quality Agreement shall commence on the Effective Date and shall remain in effect for as long as\\n    C&G Labs supplies product to  I LifeSciences.\\n                                           Page 5 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"KbGFgJd8yMW5tFA8tufdgcwNzWF38dHAtrw6EJElj6g=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_6":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_6\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"                                           QUALITY AGREEMENT REQUIREMENTS\\n              Duties                       I Austin     C&G Labs               Comments\\n                                            (Site)      (Supplier)\\n                                           Regulatory and Compliance\\n•   Follow applicable regulations\\n    and European Good\\n    Manufacturing Practices                X                X\\n    including Directive 93/42/EEC,\\n    as amended, and the U.S. FDA\\n    21 CFR 820\\n•   Any submission requirements\\n    (FDA, Notified Body, Health            X\\n    Canada, Government laws)\\n•   Technical Files                        X                          I will maintain the product\\n                                                                      technical files\\n                                                                      This will be led by the Site;\\n•   Product recall investigation           X                X         however, Supplier will provide\\n                                                                      support as requested.\\n                                                                      This will be led by the Site;\\n•   Product recall reporting               X                X         however, Supplier will provide\\n                                                                      support as requested\\n•   Establishment registration and                                    Both parties are responsible\\n    medical device listing with FDA        X                X         for maintaining Establishment\\n    and availability of registration                                  registration and medical\\n    registered form.                                                  device listing with FDA.\\n•   Facility registration with ISO         X                X         Supplier to be certified per ISO\\n    Notified Body.                                                    13485 and ISO 9001:2008, at\\n                                                                      minimum\\n                                                                      For example, moving to new\\n•   Notify I of key organizational                          X         facility, change in quality or\\n    and/or key personnel changes                                      operations management,\\n                                                                      acquisition or merger\\n•   Other Regulatory Requirements,\\n    e.g. radiation compliance, risk                                   N/A\\n    management file management\\n                                           Audit - Internal\\n•   Maintain internal Good\\n    Manufacturing Practices audit                           X\\n    program\\n•   Identify and implement corrective                       X\\n    actions to internal audits\\n                                                                      Significant findings that may\\n                                                                      affect product safety or\\n                                                                      efficacy shall be\\n•   Review of Audit report                                  X         communicated to the Site, by\\n                                                                      the Supplier’s QA Director,\\n                                                                      along with the plans for\\n                                                                      corrective action.\\n                                           Audit - External\\n                                           Page 6 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"uYyEnq+rbpjXMNhKJDFkE//0VdARB1OQ4GYbqe5ozmg=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_7":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_7\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"               Duties                         I Austin     C&G Labs                Comments\\n                                               (Site)      (Supplier)\\n                                                                          Significant findings which may\\n                                                                          affect product safety or\\n•   Review of a Notified Body or                               X          efficacy shall be\\n    FDA Audit report                                                      communicated to the Site by\\n                                                                          Supplier QA Director or\\n                                                                          designee along with the plans\\n                                                                          for corrective action.\\n                                              Design Control\\n•   Maintenance and storage of                X\\n    DHF\\n                                                                          Supplier to maintain risk\\n                                                                          management file for the\\n•   Design activities including Risk          X                X          activities performed at their\\n    Management                                                            site. Supplier should perform\\n                                                                          risk management activities as\\n                                                                          per their internal procedures.\\n                                                                          Formal supplier approval is not\\n                                                                          necessary; however, any\\n                                                                          issues with the Supplier’s\\n                                                                          ability to meet design changes\\n                                                                          shall be communicated to the\\n•   Review of Design Changes                  X                X          Site.\\n                                                                          Any change to products\\n                                                                          specification processed at the\\n                                                                          supplier site will be\\n                                                                          communicated to the supplier\\n                                                                          by I immediately upon I’s\\n                                                                          approval.\\n                                              Change Control / Document control\\n                                                                          I will inform C&G of\\n•   Review and approval of                                                Engineering changes\\n    Engineering Change pertaining             X                           pertaining to products defined\\n    to products defined in the scope                                      in the scope of this quality\\n    section of this document                                              agreement, if it impacts any\\n                                                                          cleaning activities done at their\\n                                                                          site.\\n•   Review and approve Device                 X\\n    Master Records\\n                                                                          Notification to Site if quality\\n•   Review and approval of Supplier                            X          system changes affect\\n    Quality System documents                                              products in scope of this\\n                                                                          Quality Agreement including\\n                                                                          new certificates\\n•   Review and approve Device                 X                           Record UDI information for\\n    History Records                                                       each finished device.\\n•   Notify I of all changes to facility,                                  Supplier shall notify I of any\\n    process, equipment, test                                              change to manufacturing\\n    methods, quality systems and                               X          process that may affect I\\n    specifications that impact                                            products this includes changes\\n    Product identity, safety, purity,                                     to any cleaning/\\n    stability, regulatory status or\\n                                              Page 7 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"cAK4pufBCeXG4op/G8SeN2ElzW47UFnAA5bywzPYmgM=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_8":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_8\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"               Duties                      I Austin        C&G Labs                Comments\\n                                            (Site)         (Supplier)\\n    validation/qualification. Change                                      decontamination processes,\\n    control process should account                                        chemicals etc.\\n    for changes including, but not\\n    limited to facility, process, test\\n    methods, functionality, quality\\n    specifications and approved\\n    vendor, raw materials,\\n    component specifications.\\n•   Document all required process\\n    and testing steps at the time\\n    such process or testing step is           X                X\\n    executed, e.g. cleaning and\\n    packaging validation.\\n                            Product & Process Environment (If Applicable)\\n•   Manufacture, package, ship,\\n    store, and test the Product and\\n    materials in an environment\\n    meeting the applicable GMP\\n    regulations, which is designed,\\n    constructed and maintained in a\\n    manner that a) permits the                                 X\\n    operation therein to be\\n    performed under clean, sanitary\\n    and orderly conditions, b)\\n    prevents the contamination of\\n    the Product and the addition of\\n    extraneous material to the\\n    Product.\\n•   Refrain from activity that could          X                X\\n    adversely affect the Product.\\n•   If applicable, establish and\\n    maintain a program for\\n    environmental monitoring                                   X\\n    including tracking and trending\\n    processes.\\n•   Buildings and facilities used in\\n    the manufacture of the Product\\n    shall be designed, constructed\\n    and maintained to facilitate\\n    cleaning, maintenance and\\n    operations and to ensure orderly                           X\\n    placement of equipment and\\n    materials to prevent mix-ups and\\n    contamination as appropriate to\\n    the type and stage of\\n    manufacture.\\n•   Maintain and document an                  X                X\\n    adequate pest control program\\n                                           Page 8 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"aSj/iD684bvAHjjLYIRosWeVqJfCcX+W8KwC9SrQIQQ=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_9":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_9\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"               Duties                        I Austin     C&G Labs                Comments\\n                                              (Site)      (Supplier)\\n                                                                        Supplier shall establish\\n                                                                        documented requirements for\\n•   Work Environment                                          X         health, cleanliness, and\\n                                                                        clothing for personnel involved\\n                                                                        in the manufacture of the\\n                                                                        Product\\n                                             Sterilization (If applicable)\\n                                                                        C&G labs will be responsible\\n                                                                        for validation/ revalidation of\\n•   Validation/ revalidation                 X                X         Cleaning, sterilization activities\\n                                                                        that C&G performs for I\\n                                                                        products.\\n                                             Product Release\\n•   Retains                                  X\\n                                                                        Should be done as per\\n•   Finished Goods Shipment                                   X         supplier Internal packaging /\\n                                                                        shipping procedures.\\n                                             Nonconforming Product & Out of Specification Tests\\n•   Have appropriate procedures for                                     All non-conformances are  to\\n    identification, investigation,           X                X         be handled by I and the\\n    reporting, tracking, trending and                                   supplier as per their Quality\\n    closure of deviations.                                              System.\\n•   Segregation, evaluation, and                                        All non-conformances are  to\\n    disposition of non-conforming            X                X         be handled by supplier and I\\n    product                                                             under their Quality System.\\n                                                                        Notify I within 3 business days\\n•   Approval of concession to use            X                X         of any deviation or out-of-\\n    out-of-specification material                                       specification situation affecting\\n                                                                        the quality of the Product.\\n•   Trending of nonconforming\\n    material                                 X                X         As per procedure\\n•   Provide investigation\\n    documentations to I upon                                  X\\n    request\\n•   Complete investigations within\\n    thirty (30) days of\\n    commencement. Supplier shall             X                X\\n    notify I in writing if investigations\\n    will extend beyond the original\\n    thirty (30) days.\\n•   Complete corrective action\\n    commitments resulting from               X                X\\n    investigations or complaints\\n    within the planned timeframe.\\n                                             Page 9 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"iHWz8LyInIWUJLu2CsFmcTMYe23HFoBJAg/fQfnRnqg=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_10":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_10\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"              Duties                        I Austin    C&G Labs                Comments\\n                                             (Site)     (Supplier)\\n•   Have a rework procedure for\\n    Product requiring rework\\n    describing the rationale and\\n    justification for the rework                                       Rework or Retesting\\n    processes. Rework is a                                   X         procedures require review and\\n    manufacturing step involving a                                     approval by I\\n    technique or technology that is\\n    not a part of the approved\\n    process sequence.\\n•   For any product that is reworked,\\n    record of rework is to be                                X\\n    provided to Site.\\n                                                                       I and Supplier are responsible\\n                                                                       for having a quarantine\\n•   Quarantine Procedure                    X                X         procedure and work flows as\\n                                                                       applicable during their control\\n                                                                       of the product.\\n                                            Product Complaints\\n•   Maintained finished device              X\\n    complaint files\\n                                                                       Customer complaint returns\\n•   Testing or evaluation of                X                X         may be accompanied with a\\n    complaint samples                                                  Supplier Corrective Action\\n                                                                       Request (SCAR)\\n•   Investigation of complaint root         X                X         Site may need to be involved\\n    cause                                                              when design issues are\\n                                                                       encountered\\n•   Implementation and verification         X                X         Site may need to be involved\\n    of Corrective Action Taken                                         when design issues are\\n                                                                       encountered\\n•   Complaint trending and reporting        X\\n•   Submissions of\\n    MDR/MDV/Canadian/other                  X\\n    Mandatory Reporting\\n                                            Qualification and Training\\n•   Provide sufficient training to\\n    meet obligations of this quality        X                X\\n    agreement\\n•   Only persons with the necessary\\n    awareness, skills, competence\\n    and training shall be assigned          X                X\\n    responsibilities in the product\\n    associated with this agreement.\\n•   Provide adequate number of\\n    personnel qualified by\\n    appropriate training and\\n    experience to perform and               X                X\\n    supervise the manufacture,\\n    testing, packaging and\\n    disposition of the Product.\\n                                            Page 10 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"sT5xOYr6cVbQtd1bRaXl2ge0yRvHsETlxeZ0sLXjt3M=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_11":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_11\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"               Duties                     I Austin        C&G Labs                Comments\\n                                           (Site)         (Supplier)\\n                                     Visits to Manufacturing Sites\\n•   Supplier to allow Site to visit\\n    facility(s) to review any activities     X                 X         This includes Supplier Quality\\n    pertaining to this quality                                           Audits.\\n    agreement.\\n•   Supplier to allow I Notified Body        X                 X\\n    to conduct unannounced audits\\n                                         Purchasing Controls\\n•   Supplier shall acknowledge all                             X\\n    purchase orders within 5 days\\n•   Have approved written\\n    procedures in place for\\n    qualification (including audits) of                        X\\n    suppliers that provide GMP-\\n    materials and services.\\n                                  Production and Process Controls\\n                                                                         Supplier shall ensure that any\\n                                                                         outsourced processes that\\n•   Sub-contractor validations                                 X         cannot be 100% verified, are\\n                                                                         validated by the sub-\\n                                                                         contractor.\\n•   System to ensure the proper\\n    identification and traceability\\n    during handling, storage and                               X         Products shall be traceability\\n    distribution (Product                                                by lot number/batch\\n    Classification dependent) of\\n    Product\\n•   Maintain calibrations and\\n    preventive maintenance\\n    procedures and schedules for\\n    equipment/instruments used in\\n    the manufacture, packaging,                                X\\n    testing and validation/verification\\n    of the Product. Include\\n    calibration tagging where\\n    appropriate.\\n•   Requirements for Certificates of                           X\\n    Analysis / Conformance\\n•   Document and review (including\\n    calibrations performed by Sub-\\n    Contractor) manufacturing                                  X\\n    equipment calibration data and\\n    make available to I for onsite\\n    review upon request\\n•   Implement and document\\n    specifications for raw materials,\\n    packaging materials, Product                               X\\n    labeling, and processing aids\\n    that would likely affect Product\\n    quality.\\n                                          Page 11 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"BwHhsD7hqZHnlGTSuqhJIyLQXUzu1v9UXwlPBxMXnZY=\"}","__type__":"DOCUMENT"},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_12":{"__data__":"{\"id_\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_12\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{},\"text\":\"              Duties                     I Austin        C&G Labs               Comments\\n                                          (Site)         (Supplier)\\n•   Have approved written\\n    procedures for all required in-                          X\\n    process sampling and testing.\\n•   Process equipment must be\\n    uniquely identified, status tagged\\n    and managed with an equipment                            X\\n    history log or equivalent system.\\n    Process lines will be\\n    appropriately identified.\\n•   Validated/qualify as necessary\\n    all critical systems, utilities and\\n    equipment/instruments used for\\n    the manufacture and control of                           X\\n    Product (Installation Qualification\\n    (IQ), Operational Qualifications\\n    (OQ), and/or Performance\\n    Qualification (PQ)).\\n•   Maintain shipping records                                X\\n                                        Page 12 of 12\",\"textTemplate\":\"\",\"metadataSeparator\":\"\\n\",\"type\":\"DOCUMENT\",\"hash\":\"AmPQdw1rVstWly/C7DibK8T9PxTY/mBAggb9vOxdSLQ=\"}","__type__":"DOCUMENT"},"94316b45-2459-489a-8b78-bef765de5be4":{"__data__":"{\"id_\":\"94316b45-2459-489a-8b78-bef765de5be4\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_1\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"XkUvjhfBLbDIA7i1VcxsaIgv28DigHEgaKr8nDMDwMg=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:      82005       Revision:    M        Page:       1       of      27\\n Title:             Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nTable of Contents\\nPurpose…………………………………….Page 2                        Review Output………………………….Page 11\\nScope………………………………………Page 2                          Resource Management………………Page 12\\nReferences………………………………..Page 2                      Provision of Resources…………………Page 12\\nQuality Management System (QMS)...Page 3            Human Resources…………………...…Page 12\\nGeneral Requirements………………….Page 3                  Competence, Awareness and Training..Page 12\\nDocumentation Requirements…….....Page 3             Infrastructure…………………………….Page 13\\nGeneral……………………………………Page 4                         Work Environment…………………...…Page 13\\nQuality Manual…………………………..Page 4                    Product Realization……………………Page 14\\nControl of Document…………………...Page 4                 Planning of Product Realization……..Page 14\\nControl of Records………………………Page 4                   Customer-Related Processes………Page 15\\nManagement Responsibility…………...Page 4              Determination of Requirements Related to\\nManagement Commitment…………..Page 4                   the Product…………………………….Page 15\\nCustomer Focus………………………….Page 4                     Review of Requirements Related to the\\nQuality Policy……………………………..Page 5                   Product………………………………….Page 15\\nPlanning……………………………………Page 5                        Customer Communication………….Page 15\\nQuality Objectives……………………….Page 5                  Purchasing Controls………………….Page 16\\nQuality Management System Planning  Page 7          Purchasing Process…………………..Page 16\\nResponsibility, Authority and Communication Page 9  Purchasing Information………………Page 16\\nResponsibility and Authority……………Page 9             Verification of Purchased Product…Page 17\\nManagement Representative……...Page 10               Production and Service Provision…..Page 17\\nInternal Communication…………….Page 10                 Control of Production and Service Provision Page 17\\nManagement Review………………..Page 11                    Validation of Processes for Production and\\nGeneral…………………………………Page 11                         Service Provision……………………….Page    18\\nReview Input……………………………Page 11\\nIdentification and Traceability……………..…..  Page 19\\nCustomer Property………….………………….....         Page 19\\nPreservation of Product……………………….….        Page 20\\nInspection, Measuring and Test Equipment…  Page 20\\nMeasure, Analysis and Improvement…………      Page 21\\nGeneral …………………………………………….                 Page 21\\nMonitoring and Measurement …………………         Page 21\\nCustomer Satisfaction ……………………………          Page 21\\nInternal Audit ………………………………………             Page 22\\nMonitoring and Measurement of Processes …  Page 22\\nMonitoring and Measurement of Product ……   Page 23\\nControl of Nonconforming Product …………..    Page 24\\nAnalysis of Data …………………………………..           Page 25\\nImprovement ……………………………………..               Page 25\\nContinual Improvement …………………………           Page 25\\nCorrective Action ………………………………..           Page 26\\nPreventive Action ………………………………..           Page 26\\nStatistical Techniques …………………………...       Page 27\",\"textTemplate\":\"\",\"startCharIdx\":25,\"endCharIdx\":3236,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"HE0GTSxdmmkZcI4UWeSDdnQln+rK2bWt4rGSuWptRWk=\"}","__type__":"TEXT"},"3b89a086-b28e-408d-bee0-e6da804444ef":{"__data__":"{\"id_\":\"3b89a086-b28e-408d-bee0-e6da804444ef\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_2\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"Z8ftV1u05KqnnGwCqSgHFaTNGN+wECJbOoPPt0ZZErg=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005        Revision:     M         Page:        2        of      27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nPurpose\\nCGL is a medical device company all falls under the jurisdiction of FDA as stated in 21 CFR, Part\\n820. CGL is a contract packaging company, providing decontamination, and laboratory\\nservices such as biological, bioburden, sterility, and physical testing for the medical device\\nindustry. This Quality Manual outlines policies, procedures and responsibilities for implementing\\nand managing quality related activities for CG LABORATORIES. This manual describes our\\nQuality Management System (QMS) and reflects all elements of the ISO 13485:2003 International\\nStandard and the cGMP-QSR (21 CFR, Part 820).\\nThe Process Owner of Quality Systems will coordinate the review and re-issue of the manual at\\nleast once each calendar year to insure that current practices are reflected and continual\\nimprovement of the QMS is pursued. Changes occurring between reviews will be documented\\nand filed. The appropriate personnel will be notified of the changes through documented\\nprocedures outlined in this manual.\\nExclusion is claimed to the Installation (7.5.1.2.2) and Service Provision (7.5.1.2.3), Implantable\\nDevices (7.5.3.2.2). and Design Provision (7.3) of this standard. CGL does not manufacture\\ndevices requiring Installation and Servicing nor does it manufacture implantable devices.\\nDesign is not performed at CGL because is provided specifications by Customers. These are not\\naspects of the CGL Business Strategy.\\nFor information regarding this manual, write to CG LABORATORIES, Granbury, TX.\\nScope\\nThis Quality Manual and the information contained herein directly affect all company\\ndepartments, the CGL QMS and ISO 13485: 2003 International Standard and the cGMP-QSR.\\nThis manual describes the manners in which CG LABORATORIES will consistently provide product\\nthat meets or exceeds customer and applicable regulatory requirements, and how all\\ncompany personnel contribute to the constant drive towards the enhancement of customer\\nsatisfaction. This will be demonstrated by actions such as:\\n      effective application of the system\\n      effective application of continual improvement processes\\n      assurance to conformity to customer and applicable regulatory requirements\\nAll copies of this document, which are externally distributed, will be uncontrolled.\\nCG Laboratories has two facilities;\\n      1410 Southtown Granbury, TX 76048\\n      2249 Bob White Granbury, TX 76049\\nCGL performs decontamination and medical device testing at 1410 Southtown and medical\\ndevice manufacturing and packaging at 2449 Bob White.\\nReferences\\nAll applicable level 2 reference documentation is contained at the conclusion of each Quality\\nManual section contained within the manual overview. Certain sections may also contain\\ndocumentation references within the text body.\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":2986,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"9UI4zo6vbzLOg/ZQ65Y9LR1KEFJt6VQjNcLF6CN6WVc=\"}","__type__":"TEXT"},"f189b81f-c2a9-414b-a3aa-cbe784d16d67":{"__data__":"{\"id_\":\"f189b81f-c2a9-414b-a3aa-cbe784d16d67\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_3\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"2Ln5qOVHzj5dSSwXzPYIUFoFix+yECaHYVltsNW9RVU=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\nDocument No.:       82005        Revision:    M         Page:       3        of      27\\nTitle:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nQuality Management System (QMS)\\nGeneral Requirements\\nThe CGL Quality Manual is a level one document in accordance with the ISO 13485:2003\\nInternational Standard and the cGMP-QSR. This manual defines an outline structure of the QMS\\nand its processes and serves as a direct reference for implementation and maintenance of the\\nQMS. The Quality Manual insures that all processes, work instructions and documentation satisfy\\nthe specified requirements of the customer and the ISO 13485:2003 International Standards and\\nthe cGMP-QSR. The Management Representative is responsible for establishing, implementing\\nand maintaining the QMS that is defined and documented in this Quality Manual.\\n      Documentation Requirements\\n      General\\n      Quality Manual\\nThe CGL QMS is defined, implemented and supported through a structure of procedural\\ndocumentation that is organized into various levels and categories. The levels are defined as\\nfollows;\\nLevel #\\nLEVEL #                                                                    DOCUMENTS\\n   1          The CG LABORATORIES Quality Manual,                          82005\\n   2          Procedures supporting the ISO 13485:2003 International       820XX & 820XXX\\n              Standards  and the cGMP-QSR (21 CFR, Part 820 for Medical\\n              Devices)\\n   3          Work instructions, test methods, process details, forms and  820XX-X &\\n              engineering drawings                                         820XXX-X\\nNote:       Records are an output of achieving results from tasks (can also be called\\n            documentation)\\nThe categories are characterized by a document identification system that utilizes a unique\\nnumber that relates to a primary focus area of the cGMP-QSR.\\nA complete description of the specification control procedures utilized can be found in\\nDocument and Data Control.\\nAll procedures referenced are consistent with the CGL Quality Policy CGL Management\\nRepresentative is committed to implementing and supporting this QMS and associated\\nprocedures effectively.\\nCertain military specifications may also be referenced in this manual if applicable.\\nControl of Documents- CGL Procedure 82040\\nAll documentation and data are controlled under the direction of the Process Owner of\\nDocument and Data Control and Records. Controlled documentation and data changes are\\nthe responsibility of key departmental personnel. The approval process can include both\\nelectronic or hard copy review and approval of the proposed change by affected personnel.\\nThe Management Representative has authorized certain CGL personnel to check and approve\\ncontrolled documentation. It is the responsibility of the key departmental personnel to insure\",\"textTemplate\":\"\",\"startCharIdx\":26,\"endCharIdx\":2913,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"j6w6X67BRXOroNKZO1jKIk3cPOIPFk8du7VZOKlQZNQ=\"}","__type__":"TEXT"},"905459cf-c792-4ff5-b441-8c2dd03b502c":{"__data__":"{\"id_\":\"905459cf-c792-4ff5-b441-8c2dd03b502c\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_4\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"a1ZvYlGeyQvz2oR1WXfTL+7kclTKsoQFpxyh61j+zFI=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\nDocument No.:       82005         Revision:    M         Page:        4       of       27\\n Title:              Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nthat the revised documents replace obsolete documents and are readily available for general\\naccess.\\nThe QMS documentation will continually reflect the size and complexity of the CGL\\norganization.\\nControl of Records- CGL Procedure 820180\\nCGL has established a procedure that details the control of quality records including their\\nidentification, collection, indexing, access, filing, storage, maintenance and disposition. The\\npurpose of these records is to demonstrate conformance to the specified requirements of our\\nQMS and therefore must be legible, retrievable and preserved. Retention times for each record\\nhave been established and recorded per the applicable procedure. As a minimum, all quality\\nrecords are retained for a period of ten (10) years. Supplier assessment records are also retained\\nand are available for customer review. Additional records which are retained as required\\ninclude management reviews, internal audits, corrective actions, supplier assessments,\\ncalibration, training, customer contracts, and verification, product inspection records (includes\\nrecords of nonconforming product), product identification and qualified process equipment\\nand personnel. All non-records such as procedures, forms, passed revisions or obsoleted\\ndocuments, etc. will be retained for the life of the company.\\nAs 21 CFR, Part 820 Subpart M mandates that the following records be maintained:\\nDHF   Design History File\\nDMR   Device Master Record\\nDHR   Device History Record\\nQSR   Quality System Record\\nComplaint Files (see section 7.2.3, this manual)\\nManagement Responsibility\\nManagement Commitment\\nThe CGL Management Representative is responsible for:\\n      Providing resources to implement and maintain a QMS that meets or exceeds the\\n      requirements of the ISO 13485: 2003 International Standard(s)\\n      Communicating the importance of meeting customer as well as statutory and regulatory\\n      requirements\\n      Ensuring the pursuit of continual improvement\\n      Ensuring the pursuit of established CGL Quality Policy.\\n      Ensuring the pursuit of established CGL Quality Objectives\\n      Attending management reviews as outlined in this manual\\n      The responsibility for insuring the implementation and maintenance of the QMS and that\\n      it meets or exceeds the requirements of the ISO 13485:2003 Standard rests with the CGL\\n      Management Representative.\\nCustomer Focus CGL Procedure 82020-11\\nThe CGL Management Representative meets or exceeds Customer Satisfaction by:\\n      Review and approval of customer contracts.\\n      Establishment of and adherence to customer service policies.\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":2828,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"M9h3Ad+xWuIsYbYZM1AjbKJBRpWmUaNxYKjr6q2VitU=\"}","__type__":"TEXT"},"9db29b0a-68b6-4640-97d5-ae22de5b239f":{"__data__":"{\"id_\":\"9db29b0a-68b6-4640-97d5-ae22de5b239f\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_5\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"lIZk1N4Zv40b3A2zAmGDLjDyezxtj3exiDcmqt7yhCo=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:         82005          Revision:      M          Page:         5         of       27\\n Title:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n       Resolution of differences between quotation and contract.\\n       Assurance that CGL can meet the customer contract requirements.\\nQuality Policy CGL Procedure 82020-1\\nThe C.G. Laboratories, Inc. objective is to offer Service and Guidance that shall meet customer requirements while\\nstriving to exceed customer expectations.\\nTo help achieve our ongoing commitment of customer fulfillment and confidence, the Management and staff of\\nC.G. Laboratories, Inc. are committed to complying with the requirements of ISO 13485:2003. The culture within\\nour company is built around our Never Stop dynamic which encompasses:\\n              Guidance through every process\\n              Beneficial Supplier Relationships\\n              Impeccable Product Quality\\n              Competitive Pricing\\n              Reasonable Lead-time\\n              On-time Delivery\\n              Cycle Time Reduction\\n              Cost Reduction\\n              Customer Satisfaction\\nThrough our Quality Management System, we monitor our own performance, set and monitor objectives,\\nmeasure the satisfaction of our clients, and strive to maintain a clear company-wide focus on excellence.\\nC.G. Laboratories, Inc……. where Service and Guidance Never Stops.\\nThe Quality Policy has been established with the pursuit for continual improvement of the QMS\\nas the focal point. This policy provided and continually provides the structure for the\\nestablishment and review of the CG LABORATORIES’ Quality Objectives.\\nBusiness and Quality Objectives\\n   Quality Objectives\\n       Preventive maintenance\\n           Late preventive Maintenance numbers are not trending upwards three quarters in a row\\n       Calibration\\n           Late calibration numbers are not trending three upwards quarters in a row\\n       Laboratory Department\\n           Laboratory Testing at least 95% for on-time reporting\\n              N/Cs, CAPAs, & complaints in OPEN status are not trending upwards 3 QTRs in a row\\n           N/Cs, CAPAs, & complaints issued are not trending upwards 3 QTRs in a row\\n           Complaints with a Severity of 9 or greater will be trended\\n       Packaging Department\\n           At least 90% on-time delivery\\n              N/Cs, CAPAs, & complaints in OPEN status are not trending upwards 3 QTRs in a row\\n           N/Cs, CAPAs, & complaints issued are not trending upwards 3 QTRs in a row\",\"textTemplate\":\"\",\"startCharIdx\":30,\"endCharIdx\":2588,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"tlgBLjCC58XQ/w4pLjySH7FJsYMGLl5RRpPCeWUAXBY=\"}","__type__":"TEXT"},"217c4f3b-2d2d-4c7a-b052-c0f051373038":{"__data__":"{\"id_\":\"217c4f3b-2d2d-4c7a-b052-c0f051373038\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_6\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"nTu98s1aqLCGLy7mF81ARmjer2sMV5ZVtZil5rxiI60=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:            82005           Revision:        M           Page:           6         of         27\\n Title:                    Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n            Complaints with a Severity of 9 or greater will be trended\\n        Decontamination Department\\n                N/Cs, CAPAs, & complaints in OPEN status are not trending upwards 3 QTRs in a row\\n            N/Cs, CAPAs, & complaints issued are not trending upwards 3 QTRs in a row\\n            Complaints with a Severity of 9 or greater will be trended\\n            Decon- I/Misc 1\\n                At least 90% with 1-3 day TAT\\n                Less than 9% with 4-5 day TAT\\n                Less than 1% with 5+ day TAT\\n            Decon-II/ Misc 2\\n                Same unless specified below\\n                Product discards >95% 1-5 TAT, <5% 5+ TAT\\n                Bier Vessel catheter decontamination >95% 1-5 TAT, <5% 5+ TAT\\n                Medical Device trays >95% 1-5 TAT, <5% 5+ TAT\\nHandling audits anytime and constant cleanliness and organization are hallmarks for meeting the needs of our\\ncustomers and creating an enjoyable workplace.  If quality system items are an ongoing process instead of doing\\nthese quality items all at one time, then the workplace will be less stressful and quality will increase. This creates\\nan atmosphere that is proactive and quality-driven.\\nQMS planning activities at least include identifying activities and resources needed to establish and improve the\\nquality system itself. In fact, this requirement is met through completion of other activities required by the\\nstandard:\\nCG Laboratories plans to achieve the quality objectives and ensure continual improvement through the\\nmanagement review process. Outputs of quality planning can at least include:\\n        the quality system itself (i.e. the quality manual and associated procedures)\\n        resources for establishing, maintaining and improving the quality system\\nQMS planning at CG Laboratories applies to achieving quality objectives, but also to organizational change. Changes\\nin the CG Laboratory’s organization are planned in order to minimize the risk of negative effects on quality of\\nproduct and/or service. This is accomplished through a strategic planning process. Changes and their impact on\\nthe CG Laboratory organization and the quality system is an agenda item for every management review meeting\\nand certain QRB meetings. The results of management reviews are in the form of specific actions, ensuring that\\nimprovements are made in products/services and processes/systems, and that resource needs are identified.\\nManagement review outputs at CG Laboratories will set the direction for the future (i.e. new/revised policy can be\\nissued, improvement objectives can be established, and/or specific improvement initiatives can be approved).\",\"textTemplate\":\"\",\"startCharIdx\":33,\"endCharIdx\":2909,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"7kzP1hsKYb+W+YNqpR5LlqV56bPCP6j4Jp+CzzBlGTs=\"}","__type__":"TEXT"},"34848cea-8795-46ff-ae1a-da1bfe545366":{"__data__":"{\"id_\":\"34848cea-8795-46ff-ae1a-da1bfe545366\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_7\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"5pU3KtgFvIoHi0BS7g2cbBanmg34jO8uYgo1CtwT4A0=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:        82005         Revision:     M         Page:        7        of       27\\n Title:                Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n                                            Guidance\\n                                 Cost                      Supplier\\n                               reduction                 Relationships\\n                         Cycle Time          Customer         Product\\n                         Reduction          Satisfaction      Quality\\n                                On-time\\n                                delivery                 Competitive\\n                                                           Pricing\\n                                            Reasonable\\n                                             Lead-time\\nQuality Management System Planning CGL Procedure 82020-9\\nThis Quality Manual and all supporting procedures will be referred to as the Quality Plan. The\\nManagement Representative will define planning and implementation. All Quality Manual\\nelements and referenced level II procedural documentation are means for insuring that\\nproducts and processes are in conformance to ISO 13485:2003 International Standards, the\\ncGMP-QSR and customer specified requirements.\\nThe preparation of the plan shall be the Management Representative and those process\\nowners affected by these standards and requirements. This plan will be maintained in\\nconjunction with the management review meetings.\\nThe Quality Manual is an overview of the CGL Quality System and describes our conformance to\\nthese standards and requirements. It is the responsibility of the CGL Management\\nRepresentative to maintain this manual as necessary.\\nThe QMS is a formally documented process of planned activities established to provide\\nevidence of compliance to, ISO 13485, cGMP-QSR, contractual specifications, codes,\\nstandards, military specifications, drawings, Quality Policy and Quality Objectives.\\nAll of these activities are governed by procedures, written instructions supported by records of\\ntraining and the successful compliance of products and processes.\\nTypically, QMS output planning would be in the form of the following:\\n       the quality manual\\n       operating procedures\\n       work instructions\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":2315,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"RS8fTZYA1ny+UKV7O8Q97POT6/WU1LucMosoXhkRmfQ=\"}","__type__":"TEXT"},"2ccb6209-4de4-4327-a328-8eb895a4b6f2":{"__data__":"{\"id_\":\"2ccb6209-4de4-4327-a328-8eb895a4b6f2\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_8\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"4WauzTZ+Ve7jxXdR5OqprOcdNvcNJackqJJMkZxBT1A=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005       Revision:    M         Page:       8        of      27\\nTitle:                Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n        flow charts\\n        process routings\\n        quality plans\\n Planning for resources can involve:\\n        personnel performing the verification activities\\n        personnel managing and performing the work\\n        sufficient time to do the work and verification\\n        identification of training needs\\n        obtaining appropriate equipment\\n        when applicable, development of documented procedures\\n        means of recording and accessing records\\n Considerations in the quality planning process may include the following:\\n        needs and expectations of the customers\\n        performance of the products\\n        performance operational processes\\n        learning from previous experiences\\n        risk identification and management (as well as analysis)\\n The Management Representative will control the planning, changes and implementation, of\\n procedures along with the documentation that will insure compliance to the Quality Objectives.\\n When changes are made to the QMS, care will be taken to insure integrity of the system.\\n The identification of controls and equipment needed to insure conformance to customer\\n requirements is the responsibility of the organizations or departments assigned to the immediate\\n task in conjunction with the appropriate Quality Systems’ Process Owners.\\n Planning Flow\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":1538,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"bPx4hfCjsAGZbcCsj7FBEWzdTNTvrQ80qOw1wUBPVt8=\"}","__type__":"TEXT"},"0d9c4de6-3547-40f4-b5c4-b19afb4959d6":{"__data__":"{\"id_\":\"0d9c4de6-3547-40f4-b5c4-b19afb4959d6\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_9\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"OU2h2MEGpHOJij4pI7NoKFqFXpoUprBqPYJsJpWRCgE=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:         82005          Revision:       M         Page:           9        of       27\\n Title:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n                                      Obtain order\\n                                     Existing Process/        YES         Execute order\\n                                     Existing procedures?                 according to CGL\\n                                                                          procedures.\\n                                          NO                                □  Decontaminate\\n                                                                            □  Package\\n                                      Planning                              □  Test\\n                                      □  Validation\\n                                      □  Risk\\n                                      □  Safety\\n                                      □  Resources                           Document\\n                                      □  Equipment\\n                                      □  Pricing                               Activities\\n                                      Develop                              Documentation\\n                                      procedures and                            Review\\n                                      Forms\\n                                                                             Release of\\n                                      Train                                     Service\\nResponsibility, Authority and Communication\\nResponsibility and Authority\\nThe QMS Management Representative is responsible for insuring that the QMS is implemented\\nand maintained and that it meets or exceeds the requirements of the ISO\\n13485:2003International Standards and 21 CFR, Part 820 and achieves CGL Quality Policy and\\nQuality Objectives.\",\"textTemplate\":\"\",\"startCharIdx\":30,\"endCharIdx\":1931,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"Dc8QoSngO1pX5t3XqUS3lUrd0G7GFiT/Y+KNpV+vlzg=\"}","__type__":"TEXT"},"5683575c-685b-4705-b81f-bf2ee20a9dc6":{"__data__":"{\"id_\":\"5683575c-685b-4705-b81f-bf2ee20a9dc6\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_10\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"Cm1ihZHp3CPbNNKXMD0daSjkuQJoE/6jlrrIgYc78qI=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        10       of       27\\n Title:                               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nManagement Representative\\nThe GM of CG LABORATORIES is the Management Representative. The Management\\nRepresentative will inform top Management of:\\n      QMS performance\\n      state of the QMS\\n      the need for improvement (as needed)\\nThrough ongoing review of Quality Objectives, Customer Satisfaction monitoring and analysis,\\nthe Management Representative will promote customer requirements awareness throughout\\nthe organization.\\nInternal Communication CGL Procedure 82005-2\\nThe CGL General Manager and Management Representative, are responsible for providing\\nresources to communicate, implement and maintain the QMS that meets or exceeds the\\nrequirements of the ISO 13485:2003International Standards and the cGMP-QSR, and achieves\\nour Quality Policy and Quality Objectives.\\nCommunication regarding the effectiveness of the QMS is enacted and documented.\\n                             Top\\n                          Management\\n                             Sales\\n            Service Core                  Customer\\n            Competency                    Service\\n  Q                                                   Internal\\n  QRB                                                  Audit\\n                                                        Team\\n                       Total Customer Satisfaction\\n                 Operations               Quality Systems\\n                            Manufacturing Core\\n                            Competency\\n                   Information Systems\",\"textTemplate\":\"\",\"startCharIdx\":38,\"endCharIdx\":1731,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"Cbz+s2I7/LIaojXZThGWi3TpCyamNz2klQwnUGc6IE0=\"}","__type__":"TEXT"},"507b68f1-d7f4-4172-9591-3675f41318ff":{"__data__":"{\"id_\":\"507b68f1-d7f4-4172-9591-3675f41318ff\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_11\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"kmfdKjIHTxM/RQeSOV3kTfDyKQtXL+aRjg9yFQ148ZA=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\nDocument No.:       82005         Revision:    M         Page:       11       of       27\\n Title:              Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nManagement Review CGL Procedure 82020-5\\nGeneral\\nQuality System audits are performed regularly by either internal resources or external sources to\\nprovide management with feedback and to insure its continuing suitability, adequacy and\\neffectiveness of the Quality System. Internal audits are used to evaluate the implementation\\nand the effectiveness of the Quality System and compliance of the Quality System against\\ncriteria based on ISO and cGMP-QSR. The Management Representative will review the Quality\\nSystem for effectiveness at a minimum of two times every twelve- (12) months. In addition,\\nmanagement will review performance relative to quality and other business metrics at the\\nManagement review meetings.\\nReview Input\\nDuring specified CGL QMS management reviews, the Management Representative will present\\nat least the following information on:\\n      audit results\\n      customer feedback\\n      process performance and product conformity\\n      status of preventive and corrective actions\\n      follow-up actions from previous management reviews\\n      changes that could affect the QMS and recommendations for improvement\\nOther considerations for information may be, but not limited to, the following:\\n      market place evaluation including the performance of competitors\\n      results of benchmarking activities\\n      performance of suppliers\\n      status of achieving the Quality Objectives\\n      changes in original assumptions, arising from new technologies, outputs of R & D, quality\\n      concepts, financial, social, environmental conditions and legislative or regulatory\\n      changes\\nThe review process may also revolve around the consideration of the following when\\napplicable:\\n      checking the relevance and the achievement of the existing Quality Policy and Quality\\n      Objectives\\n      updating policies and objectives as necessary\\n      Improvement plans for the overall effectiveness, adequacy and suitability of the QMS.\\n      measures to insure satisfaction of customers\\n      improvement to production processes, including reduction of scrap\\nReview Output\\nThe Management Representative will take actions, relevant to the applicable review input\\ncriteria, related to improvement of the QMS and its processes, improvement of product related\\nto customer requirements, and resource needs. These actions, at a minimum, will meet the\\nrequirements of the ISO 13485:2003International Standards and 21 CFR, Part 820.\\nRecords of management reviews will be maintained and may be in the form of, but not limited\\nto, one or more of the following:\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":2784,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"KBcNzBPXQkZIUv9TUOlHODlMLvIrywIjf3+fKM/hG/o=\"}","__type__":"TEXT"},"05693ea2-2916-46ae-9d99-ab995ff80e6f":{"__data__":"{\"id_\":\"05693ea2-2916-46ae-9d99-ab995ff80e6f\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_12\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"d2hX49SlMEfhygENWrM2exyJE5PJ5HDEjrS6a3Veaw4=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        12       of      27\\nTitle:                Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n        minutes potentially leading to CAPA initiatives\\n        agenda\\n        attendance list\\n Information contained in the records may include, but not limited to, one or more of the\\n following:\\n        who performed the review\\n        when the review occurred\\n        what was reviewed\\n        results of the review\\n        action items\\n        assignment of action items into the corrective and preventative action process (CAPA)\\n        status of previously assigned items\\n        conclusions\\n Resource Management\\n Provision of Resources\\n The Management Representative is responsible for identifying and making available the\\n necessary resources for performing Quality System activities that will meet or exceed the\\n requirements for products and service that will enhance customer satisfaction. Appropriate\\n training will be given to company personnel in their specific work functions and associated\\n Quality System activities.\\n Human Resources\\n General\\n When personnel are given assigned responsibilities that may have an effect on product quality,\\n the assigned responsibilities will be defined and be based on appropriate education, training,\\n skills and experience.\\n Note:  Where the expression “or equivalent” is used, as it relates to competence requirements, it\\n may be defined as one of the following:\\n        quantitative – an x number of years experience in lieu of formal education\\n        a determination made by the interviewer, Management Representative, or top\\n        management as a result of the interview process\\n Competence, Awareness and Training CGL Procedure 82025\\n The training of CGL personnel is focused on achieving the required skills necessary to supply\\n products and services that meet or exceed customer expectations.\\n The identification and approval of the required training is the responsibility of the Training\\n Process Owner, Supervisors, and potentially the Management Representative.\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":2149,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"Ldwnp04bYKyE41F43Y/5n8OweDabdwKdAd4Fxo/B9KY=\"}","__type__":"TEXT"},"ca4adf06-be37-4ac9-907d-d639c8e87e2f":{"__data__":"{\"id_\":\"ca4adf06-be37-4ac9-907d-d639c8e87e2f\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_13\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"YKDa17z6h0AOYRkk5wjGtD12NeRfukftYvgFIjLJ6ic=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        13       of      27\\nTitle:                Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n The assigned responsibilities will be determined and documented and may be in the form of,\\n but not limited to, the following:\\n       job descriptions by function and responsibilities\\n       second-level procedures\\n       work instructions\\n       specifications\\n A variety of external and internal sources including procedural documentation, work\\n instructions, courses, seminars, conferences and individual study programs are utilized. Training\\n for subcontractors or temporary employees is always administered where appropriate.\\n The Document and Data Control Process Owner retains all training records of education,\\n experience, skills, training and qualifications including certifications, registrations and degrees\\n granted. Records can be in the form of:\\n       CGL training record\\n       signed application\\n       resume/CV\\n       copies of certificates\\n       diploma\\n       training attendance sheets\\n Personnel effectiveness training can be measured by, but not limited to, one or more of the\\n following:\\n       pre and post training testing\\n       internal auditing\\n       Monitoring of process performance in terms of defectives and responsibility for same.\\n Infrastructure\\n All buildings, workspaces, utilities, process equipment and associated supporting services which\\n directly affect quality, have been identified and planned to insure that conformity of product\\n requirements is achieved and maintained.\\n Work Environment\\n CG LABORATORIES employs a work environment that is suitable for all activities performed that\\n may affect product quality and ultimately customer satisfaction. Taken into consideration are\\n environmental conditions such as:\\n       lighting\\n       ergonomics\\n       work area cleanliness\\n       equipment orientation\\n       health, cleanliness and clothing of personnel\\n       spatial separation of product\\n       documented requirements for environmental conditions in assembly and component\\n       areas\\n       temporary employees follow the same rules as full and part-time employees and are\\n       trained accordingly\\n For calibration, consideration is given to environmental conditions such as:\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":2363,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"sMgaj85dwseVIR1pW3WKq8oCdflTCXWudMS/+8Wj1UQ=\"}","__type__":"TEXT"},"d17e4b4a-d77e-49ca-9738-c830b7887942":{"__data__":"{\"id_\":\"d17e4b4a-d77e-49ca-9738-c830b7887942\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_14\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"bZWDyESHUEmr1Ai3vFL2WY/ysXhXsllA28ZkrMuqPks=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005         Revision:    M         Page:        14       of       27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n       ambient temperature\\n       humidity\\n       vibration\\n       equipment proximity\\n Product Realization\\n Planning for Product Realization\\n This Quality Manual and all supporting procedures will be referred to as the Quality Plan. The\\n Management Representative will define planning and implementation\\n CGL documents all procedures and records for inspection and testing to verify that the\\n specified requirements have been met and to confirm achievement of process and product\\n conformity. Acceptance criteria for all activities as they relate to the verification, validation,\\n monitoring, inspection and testing of product, along with the related project(s) and contract(s),\\n have been determined with the quality objectives in mind.\\n As part of product realization, when a new product is introduced at CGL, or an existing product\\n is considered for modification, consideration will be given to the need for new processes and\\n resources or the modification of existing processes and resources to fit the needs of the specific\\n product. More preventive requirements considered are, but not limited to:\\n       criteria for workmanship\\n       environmental control\\n       personnel requirements\\n       contamination control\\n       buildings\\n       equipment\\n       automated processes\\n Risk Management:\\n ISO 13485 requires that organization establish documented requirements for risk management in\\n the product realization process. In the case of C.G. Laboratories, Inc. this has a direct impact on\\n process-related assessments. Directly, product-related risk management is the customer’s\\n responsibility unless contractually established for each unique situation. Risk management\\n includes risk assessment, risk analysis and risk reduction. Risk Assessment is identifying risks. Risk\\n Analysis is looking at the probability and severity of all hazardous situations. Risk reduction is\\n reduction, mitigation, elimination of risk as much as possible.\\n Risk management applies to quality management system processes in the case of C.G.\\n Laboratories Inc. and it also applies to the design of the device, manufacturing and supporting\\n services as delineated by C.G. Laboratories, Inc. customers in their formal requirements’\\n documentation. Risk management is such an important process that ISO 13485 requires risk\\n management is done in accordance with ISO 14971. The international standard for medical\\n device risk management is ISO 14971:2007 and EN ISO 14971:2012 (for customers requiring same\\n for CE Marking in Europe).\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":2750,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"uXK2SoizNqXGe33BXQQO2g77RMPrZmC1xxl6NX+/Bpc=\"}","__type__":"TEXT"},"1fd02afd-deae-4a6c-93ec-71bcf6b0e120":{"__data__":"{\"id_\":\"1fd02afd-deae-4a6c-93ec-71bcf6b0e120\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_15\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"01orx0SuNjvDUyCzCGf9q3Q9Fa26qSSZvIRwjZlqGA0=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        15       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nRisk Management provisions will be employed throughout these processes.\\nCustomer-Related Processes\\nDetermination of Requirements Related to the Product/ Service\\nIt is the joint responsibility of every employee to insure that, while interfacing with the customer,\\nthe product/service requirements are identified and documented, from conception to\\ncustomer receipt to the intended use of the product. Additionally, this joint responsibility\\nencompasses any statutory and regulatory requirements related to the product.\\nReview of Requirements relating to the Product/ Service\\nAll customer requirements reviews take place prior to order acceptance. An amendment to a\\ncontract is initiated using the same procedures followed when establishing the initial contract.\\nRecords of new and current contracts including amendments to those contracts are retained\\nand the full responsibility by and of the Process Owner for Records.\\nThe responsibility of reviewing customer requirements can be a combined or the sole effort of\\nthe Management Representative.\\nCustomer Communication\\nThe first point of customer contact as it relates to product information, inquiries, contracts or\\norder handling, including amendments, customer feedback and customer complaints will be\\nthe sales personnel or customer service for that department. Determination of inquiry\\nassignment will be as per CGL documented procedures.\\nComplaint files CGL Procedure 820100\\nThe CGL organization has made provisions for the following requirements:\\nComplaint files and procedures are established and maintained for receiving, reviewing, and\\nevaluating complaints by a formally designated unit. Such procedures ensure that:\\n      all complaints are processed in a uniform and timely manner;\\n      oral complaints are documented upon receipt; and\\n      Complaints are evaluated by QRB to determine whether the complaint represents an\\n      event, which is required to be reported to FDA, Medical Device Reporting.\\n      The QRB shall review and evaluate all complaints to determine whether an investigation\\n      is necessary. When no investigation takes place, the CGL shall maintain a record that\\n      includes the reason no investigation occurred and the name of the individual responsible\\n      for the decision not to investigate.\\n      Any complaint involving the possible failure of a device, labeling, or packaging to meet\\n      any of its specifications shall be reviewed, evaluated, and investigated, unless such\\n      investigation has already been performed for a similar complaint and another\\n      investigation is not necessary.\\n      Any complaint that represents an event which must be reported to FDA under part 803 or\\n      804, shall be promptly reviewed, evaluated, and investigated by a designated\\n      individual(s) and will be maintained in a separate portion of the complaint files or\\n      otherwise clearly identified. In addition to the information required by Sec. 820.198(e) of\\n      cGMP Title 21 CFR part 820, records of investigation under this paragraph will include a\\n      determination of:\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":3302,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"Y/+8yZ8CDRB138DaFBLwGjjQhMf7cXR14iLIkiowe+w=\"}","__type__":"TEXT"},"83b4fd1f-af3a-4f61-8e76-e9107112f8e4":{"__data__":"{\"id_\":\"83b4fd1f-af3a-4f61-8e76-e9107112f8e4\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_16\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"tx9yHl95ys5XSxHiCJMMSY0WfkCWyNJkylo7jaRaUGM=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        16       of      27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n          o  whether the device failed to meet specifications\\n          o  whether the device was being used for treatment or diagnosis; and\\n          o  the relationship, if any, of the device to the reported incident or adverse event\\nWhen an investigation takes place under this section, the formally designated unit for handling\\ncomplaints will maintain a record of the investigation. The record of investigation will include,\\nbut not limited to:\\n      the name of the device;\\n      the date the complaint was received;\\n      any device identification(s) and control number(s) used;\\n      the name, address, and phone number of the complainant;\\n      the nature and details of the complaint;\\n      the dates and results of the investigation;\\n      any corrective action taken; and\\n      any reply to the complainant\\n      If, in the event a the formally designated complaint unit is located at a site separate from\\n      the CGL manufacturing establishment, the investigated complaint(s) and the record(s) of\\n      investigation will be reasonably accessible to the manufacturing establishment.\\n      If, in the event a the formally designated complaint unit is located outside of the United\\n      States, required records will be reasonably accessible in the United States at one of the\\n      following locations:\\n          o  in the United States where the manufacturer's records are regularly kept; or\\n          o  the location of the initial distributor\\nPurchasing\\nPurchasing Process CGL Procedure 82050\\nPurchasing activities include selection, evaluation and assessment of suppliers, contractors,\\nconsultants, etc., i.e. product and/or service procurement and verification that purchased\\nproduct and/or service conforms to specified requirements. This applies to all inventory items,\\nsupplies and capital equipment for CGL.\\nCGL evaluates and selects subcontractors based on their ability to meet CGL Quality, Cost and\\nDelivery requirements.\\nContinued use of a supplier, contractor and/or consultant will depend on product or service\\nquality, delivery and cost.\\nQuality records for all suppliers supplying inventory materials are maintained.\\nCGL maintains supplier evaluation categories. Suppliers’ categories are updated by QRB, when\\nproduct or equipment is supplied to CGL.\\nPurchasing Information\\nCGL purchase orders and/or included documentation contain a clear definition and/or\\ndescription of all requirements. This includes:\\n      price and delivery\\n      part number or model number\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":2718,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"CumrZou1BR9uYBtueKCN3qMxUdKAGvMID3V4tMtknBA=\"}","__type__":"TEXT"},"8435bed3-e5f6-4ac0-b9af-b9387e0d4cb7":{"__data__":"{\"id_\":\"8435bed3-e5f6-4ac0-b9af-b9387e0d4cb7\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_17\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"r5sFvFWbJ+90IL2COULgJ/gtshucMNRJz/bFFc9xp1g=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005         Revision:    M         Page:        17       of       27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n       material description\\n       specifications and drawings (revisions, thereof)\\n       inspection instructions or specific requirements\\n        any other technical or contractual requirements that may apply\\n Purchasing documentation will include, where possible, an agreement that suppliers,\\n contractors, and consultants agree to notify and obtain explicit written approval from CG\\n LABORATORIES of any changes in the product or service so that it may be determined whether\\n the changes affect the quality of a finished device and / or service performed.\\n The Purchasing Process Owner is responsible for reviewing and approving purchasing\\n documents for accuracy of specified requirements prior to release.\\n Verification of Purchased Product\\n Where specified in the contract, CGL has the authority to verify at the supplier’s facility, that\\n purchased product conforms to specified requirements.\\n Incoming product will be inspected by receiving inspection. Verification of conformance to\\n specified requirements is in accordance with CGL documented procedures. Retention of\\n verification records will follow the section for Records of this document.\\n Suppliers, subcontractors and consultants will assure quality of product and/or service through a\\n quality system that meets CGL quality requirements. Evidence of compliance to these\\n requirements will be determined through the Certificate of Conformance and/or Certificate of\\n Analysis, audits as necessary and continued monitoring of certain aspects of quality, cost, and\\n schedule.\\n Production and Service Provision\\n Control of Production and Service Provision CGL Procedure 82070\\n All production processes, which directly affect quality, have been identified and planned to\\n insure that these processes are carried out under controlled conditions.\\n Included with needed process controls are:\\n       documented instructions, standard operating procedures (SOP's), and methods that\\n       define and control the manner of production\\n       monitoring and control of process parameters and component and device\\n       characteristics during production\\n       workmanship criteria\\n       compliance with specified reference standards or codes\\n       the approval of processes and process equipment\\n As product is prepared for delivery, manual or electronic systems provide current shipping and\\n routing information. With implemented and defined labeling and packaging operations,\\n shipping labels and documents are generated electronically utilizing bar code technology, if\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":2755,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"mVA/EjLe4GJZMzXJkp5TbjE0kL8ugnpABmqy+GAigno=\"}","__type__":"TEXT"},"175c55bf-34ae-481a-9a9f-04aab46452ce":{"__data__":"{\"id_\":\"175c55bf-34ae-481a-9a9f-04aab46452ce\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_18\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"ylxWhPyOajP03cTqxykW1DK9ZJytvqgmzspLfKldm58=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:     M         Page:        18       of      27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nspecified by the customer, to prevent errors. The customer determines the transportation type\\nand site destination of product via the desired carrier.\\nCGL guarantees its devices according to the terms and conditions of its order\\nacknowledgement and invoice documents.\\nThe Quality System’s Process Owner is responsible for resolving all quality related customer\\ncomplaints.\\nCustomer quality inquiries are reviewed by the GM. Appropriate action is taken by the\\ndepartment supervisor to evaluate and resolve the customer’s problem. Quality Systems may\\nbe contacted for customer consultation. CGL Quality Systems may be called on for evaluation\\nand support.\\nQuality Systems may generate return Material Authorization (RMA) numbers. Purchasing can\\ninitiate credit memos for valid return of goods, price corrections or other customer service\\nrelated reasons. The General Manager is responsible for final approval of customer credits and\\ngenerates the credit document.\\nDocument and Data Control maintains records of all quality related customer problems as well\\nas records of non-quality related customer problems in a controlled file. Accounting retains all\\ncredit memos on file.\\nValidation of Processes for Production and Service Provision\\nQualified operators will enact the validation of any process where deficiencies may only be\\napparent after the product is in use. The validation process will include (as applicable), but not\\nlimited to:\\n       manufacturing orders, product drawings, process specifications, procedures and work\\n       instructions that have defined workmanship criteria that is subject to review and approval\\n       the master validation plans for process, product and software\\n       specific methods and procedures such as selection and control of equipment used in the\\n       manufacture of product, which is accomplished through calibration, maintenance and\\n       preventive maintenance programs to insure capability and product quality. Provisions for\\n       controlled environments are available when necessary\\n       qualification records for processes and key personnel, as necessary\\nWhen changes or process deviations occur, CGL Process Owner of Validation reviews and\\nevaluates the process and performs revalidation where appropriate and documents these\\nactivities. The master validation plan(s) for process, product and / or software are the drivers for\\nthe validation efforts at CG LABORATORIES.\\nExclusion\\nDue to the nature of CGL Products and their end use by the customer, exclusion is claimed to\\nthe Installation and Service Provision of this section. CGL products are not installed and/or\\nserviceable, but rather replaceable.\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":2884,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"MwkLumjud957HcSeVuirjiUz/rOjfpGjuzutEI6raX4=\"}","__type__":"TEXT"},"5c0d9550-26cc-4b88-b04d-e28182397ef5":{"__data__":"{\"id_\":\"5c0d9550-26cc-4b88-b04d-e28182397ef5\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_19\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"c8QPaPuYzbePsKGyu/S/8xpXT0Omhc35QPJGf3AXy18=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        19       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nIdentification and Traceability CGL Procedure 82060\\nProduct identification and traceability is facilitated manually or using validated software and\\nmaintained at all stages, from receiving to delivery into the marketplace. The means by which\\nproduct is identified are manufacturing orders, move documentation, identification tags and/or\\nlabels. Product status is also identified with respect to monitoring and measurement\\nrequirements. Subassembly parts, assemblies or final products that have passed required tests or\\ninspection, and in the process of being moved to the next production phase or final disposition\\nare identified to indicate inspection status. One or more of the following methods may be used:\\n      tags\\n      stamps\\n      labels\\n      inspection and test records\\n      move documentation\\n      process worksheets\\n      corrective action/rejection reports and/or status\\nCGL has established and maintains procedures to insure that Device History Records (DHR) for\\neach batch, lot, or unit are maintained and verified to demonstrate that the device is\\nmanufactured in accordance with the DMR and the requirements of this section.\\nManually derived and administered documentation, as it relates to inspection and test results of\\nproduct, are maintained for the release of conforming product. Inspection records are\\nmaintained by Document and Data Control to show that the product has passed all defined\\nacceptance criteria.\\nAll devices will be traceable to the supplier lot. All products will be identified with an inspection\\nand item number.\\nTo show that product has been inspected and/or tested, Document and Data Control\\nmaintains the records that provide this evidence. These records indicate whether product\\nconforms to established quality standards. Where the product fails to pass any inspection\\nand/or test, the procedures for nonconforming product shall apply. Records identify the\\ninspection authority responsible for the release of the product.\\nCustomer Property\\nWhen required by the contract, the customer may furnish material to CGL for specific\\nproduction purposes.\\nSuch materials are subjected to the same control measures as subcontractor and in-house\\nproduced product. This includes receiving inspection for verification of conformance, material\\nidentification and traceability, controlled and protected stock or storage, manufacturing\\ncontrol and final or completed product inspection.\\nRecords detailing the control of customer-supplied product per the above-described areas are\\navailable for customer review.\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":2764,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"nszEm5EyRnCilsSjgd3GaYW5yRrBbg/FaSAQGzRLYpA=\"}","__type__":"TEXT"},"be680354-79b2-4856-ad09-c6aec348aa66":{"__data__":"{\"id_\":\"be680354-79b2-4856-ad09-c6aec348aa66\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_20\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"gjf7wuHcBUd2H8mBgWPhyoKVVTpmLdowsy3M1wWw/fU=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:     M        Page:        20        of      27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nWith the identification of any nonconformance during the inspection and handling of these\\nmaterials, immediate notification of the customer takes place for purposes of product lot\\ndisposition. CGL has and maintains a record of such occurrences.\\nPreservation of Product\\nCGL has established procedures for handling, storage, packaging, preservation and delivery of\\nproduct.\\nProducts that require special handling have detailed requirements as part of the customer\\nspecification, manufacturing order or engineering drawing. In the absence of a specified\\nrequirement, the utilization of standard operating procedures will become the default to\\nmaintain product integrity.\\nThe use of controlled and secure stock locations is to prevent product damage or deterioration\\nand to maintain lot control. Product issued to the production floor or for customer delivery is\\nstored separately and handled by warehousing and manufacturing personnel. CGL products\\nare handled on a first in, first out basis. In-process or final product that require non-standard\\nstorage to prolong or protect product shelf life and general integrity, has such requirements\\nspecified per the appropriate product documentation. Where appropriate, an assessment of\\nproduct shelf life will be done.\\nAll standard in process and final product packaging is designed to protect the material from\\ndamage or deterioration and maintain lot control. Non-standard packaging or marking\\nrequirements as specified per customer specifications or contracts are controlled by\\nappropriate procedures.\\nAppropriate and necessary methods and practices are utilized in the preservation and\\nsegregation of product\\nControl of Inspection, Measuring and Test Equipment CGL Procedure 82072\\nCGL has established documented procedures, with guidance from ISO 17025, for controlling\\nthe calibration of all test and measurement instrumentation. This includes gages, instruments,\\nsensors, test equipment and related software used in the development, production, installation\\nand servicing of product. The objective of our calibration program is to provide a system that\\nassures conformance to specified requirements, calibrated standards and confidence in\\nmeasurement data.\\nQuality Systems determines the pertinent measurements and the degree of accuracy required\\nby appropriate inspection and measuring test equipment.\\nStandards and equipment used for calibration are traceable to N.I.S.T. Measuring and test\\nequipment is tagged as follows, indicating calibration status:\\n       Calibration date\\n       Next calibration date\\n       Serial and asset numbers (original manufacturer S/N if applicable and an CGL asset #)\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":2872,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"ftOhCNVDy53UgHkfk1j0Q0LEbxzKdO5EyZrxtwJp/WQ=\"}","__type__":"TEXT"},"dd56c4be-91ca-445a-af45-822891aba1aa":{"__data__":"{\"id_\":\"dd56c4be-91ca-445a-af45-822891aba1aa\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_21\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"4X44Ue2w5o1UM5RyCopu1LjD+qFySrKLm2iA3ZNxjUs=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005        Revision:     M         Page:        21       of      27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n       Calibrated by\\n Calibration of inspection, measuring and test equipment, including details of equipment type,\\n unique identification, location, frequency of checks, check method, acceptance criteria and\\n the action to be taken when results are unsatisfactory are described in Calibration System\\n Requirements delineated for each unique and / or particular measuring device.\\n CGL maintains calibration records of all inspection, measuring and test equipment. These\\n include records of equipment calibrated on or off site.\\n When out of calibration conditions are detected, inspection, measuring and test equipment is\\n re-calibrated, repaired or replaced and affected product re-tested per CGL procedures.\\n Environmental conditions suitable for calibration, inspection and measurement are defined in\\n CGL procedures.\\n To insure that accuracy and fitness for use is maintained, inspection test and measurement\\n equipment is located in secured areas and handled by authorized personnel.\\n Inspection measuring and test facilities, including both test hardware and test software are\\n protected from adjustments that would invalidate the calibration setting per the CGL\\n procedure.\\n Measurement, Analysis and Improvement\\n General\\n In an effort to meet the specified requirements of the International Standards and 21 CFR, Part\\n 820, CGL has planned, implemented and performs the measurement and analysis activities to\\n assure product conformity and efforts toward continual improvement of the QMS.\\n The use of statistical methods, among other techniques, is beneficial to establish, control and\\n confirm desired process and product characteristics. Statistical tools such as histograms, process\\n control charts, trend analysis and / or praeto charts, etc. may be utilized as appropriate in the\\n following areas:\\n       Quality Systems\\n       Manufacturing\\n       Internal audit results assessment\\n       Product performance assessment\\n       Supplier Performance\\n       Complaints and Adverse Events\\n Procedures describing applicable statistical techniques are contained in the production,\\n inspection and design review procedures.\\n Monitoring and Measuring\\n Customer Feedback and Satisfaction\\n CGL will assume a proactive role in the determining the level of customer satisfaction and/or\\n dissatisfaction. This will be accomplished by measuring these levels and monitoring whether the\\n customers needs are being met. The acquisition of data will be centered on areas that are\\n important to our customer base and may come from, but not limited to, methods such as:\\n focus groups\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":2801,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"vpfiwhEED9F5RuE+YKUF0IjgcOpnB1mHQ5x+I4lShzo=\"}","__type__":"TEXT"},"f2a9b181-8a3b-4d5b-a3b7-a788368c1858":{"__data__":"{\"id_\":\"f2a9b181-8a3b-4d5b-a3b7-a788368c1858\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_22\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"yQPt1z5zRmo02av2J9wGqbRwf4Vw+X+4grfzserw2Ks=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005         Revision:    M         Page:        22       of       27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n        customer visits – regional sales managers, key account managers, company\\n        representatives, quality system personnel\\n        customer satisfaction surveys\\n        customer complaints\\n        direct communication with customers – account managers, quality system personnel\\n        customer organization reports\\n        media reports\\n        sector studies\\n Internal Audit CGL Procedure 82022\\n The QMS is monitored for, ISO 13485:2003 and 21 CFR, Part 820 compliance by an internal audit\\n process and cross-functional audit team (seeks guidance from ISO 19011). This process includes\\n audits designed to evaluate all systems, policies, procedures, processes and products within the\\n organization that affect product quality or service.\\n The audit process covers quality system audits in compliance with IS0 and cGMP-QSR Quality\\n System requirements. This includes audits of procedures and work instructions as well.\\n Internal audits are scheduled and conducted based on previous audit results and the status\\n and importance of the activity. Personnel independent of those audits having direct\\n responsibility for the audited activity conduct them.\\n Audit results including required improvements become a matter of record and then forwarded\\n to the management personnel having responsibility for the area audited.\\n Specific management personnel responsible for the area under audit will take the necessary\\n corrective action without undue delay to eliminate the nonconformities and report the\\n verification results.\\n Follow-up audit activities are performed to verify the results and effectiveness of the corrective\\n action taken.\\n The internal audit process results are reviewed at least four times every twelve (12) months\\n during management review. This review is an integral part of the input and output to\\n management review activities and general QMS improvements.\\n Monitoring and Measuring of Processes\\n In determining if a CGL process has the ability to satisfy its intended use / purpose, which\\n includes active implantable devices and / or one-use devices, consideration may be given to\\n all or part of the following attributes:\\n        repeatability\\n        timeliness in a process or personnel performing a task\\n        the competency level of personnel performing tasks\\n        process constraints related to equipment and / or material availability\\n        revalidation opportunities\",\"textTemplate\":\"\",\"startCharIdx\":29,\"endCharIdx\":2635,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"Bl/vs5PsHdQp7pet0xGP7ffTp1yuMPJcFlHSWzCq3tY=\"}","__type__":"TEXT"},"6b386c8c-74ba-4bf6-a1d5-34e9b85f7805":{"__data__":"{\"id_\":\"6b386c8c-74ba-4bf6-a1d5-34e9b85f7805\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_23\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"A3hKm8ahkG2cUbKMDvZBuaN62KlDsPwH58GE2EoAc2w=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n  Document No.:       82005        Revision:     M         Page:       23       of       27\\nTitle:                 Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n Where needed, essential process controls and validation are:\\n       documented instructions, standard operating procedures (SOP's), and methods that\\n       define and control the manner of production;\\n       monitoring and control of process parameters and component and device\\n       characteristics during production;\\n       compliance with specified reference standards or codes;\\n       the approval of processes and process equipment; and\\n       criteria for workmanship that shall be expressed in documented standards or by means of\\n       identified and approved representative samples.\\n Depending on product type, the use of suitable methods for monitoring, and if applicable, the\\n measuring of the QMS processes may include, but not limited to, one or more of the following:\\n       measuring reaction time\\n       cycle time\\n       measurable aspects of dependability\\n       efficiency of the process\\n       waste reduction\\n       cost allocation and reduction\\n When planned results are not achieved when using the decided methods, correction will be\\n made and corrective action will be taken.\\n Monitoring and Measuring of Product\\n Incoming Inspection – incoming product and raw material requires inspection, testing, or\\n otherwise verified as conforming to specified requirements prior to release. Verification of\\n conformance to specified requirements is in accordance with the CGL quality plan and\\n documented procedures.\\n Suppliers, subcontractors and consultants will assure quality of product and/or service through a\\n quality system that meets or exceeds CGL quality requirements. Evidence of compliance to\\n these requirements will be determined through the Approved Supplier process (list).\\n There will be no use, processing or release of incoming product until its verification as\\n conforming to established requirements by means of inspection is complete.\\n Sampling Plans – reference to ANSI Z1.4 or Z 1.9 will be made for sampling plans.\\n First Article Inspection – is the submission of product to inspection prior to the start of any\\n manufacturing order to confirm process control and product conformance.   The start of a\\n manufacturing order will not be granted until approval of first piece inspection is granted.\\n In-Process Inspection - confirms in-process manufacturing control by periodic operator on-line\\n inspection and submittal of product for final in-process inspection. Recording of these results is\\n limited to final in-process inspection only.\",\"textTemplate\":\"\",\"startCharIdx\":28,\"endCharIdx\":2704,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"Gg9PenzynB/8Mn/qBtA9kYftZAq/fOv6MmCxJiU5hyA=\"}","__type__":"TEXT"},"7b0b191a-c225-4309-8c80-0b08ef75df8e":{"__data__":"{\"id_\":\"7b0b191a-c225-4309-8c80-0b08ef75df8e\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_24\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"cFaPXimwr+r99srRXe0kBssxFau/+3kqflKFrUD0H+M=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        24       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nFinal Inspection – confirms final assembly control by testing in accordance with the CGL Quality\\nPlan under the guidelines of the inspection process and DHR review/disposition. Finished\\nproduct is not shipped pending review of documentation requirements as designated by 21\\nCFR, Part 820.80.\\nNote: Acceptance status is documented for all inspections.\\nInspection records provide evidence that product verification as it relates to in-house, customer\\nand regulatory requirements and that testing was completed. These records indicate whether\\nproduct conforms to established quality standards and CGL specifications. Where the product\\nfails to pass any conformity requirements and/or test, the procedures for nonconforming\\nproduct shall apply. Records identify the inspection authority responsible for the release of the\\nproduct.\\nWhen planned results are not achieved when using the decided methods, correction will be\\nmade and corrective action will be taken.\\nOther methods of measuring and/or monitoring not mentioned above may include, but not\\nlimited to, the following:\\n      product audits monitoring specified activities\\n      operator in-process inspection\\n      automated inspection and test\\n      monitoring in-process instrumentation that controls processes or testing samples taken at\\n      defined locations and intervals\\n      fixed inspection stations at intervals throughout the process\\nControl of Nonconforming Product 82090-2\\nThis section covers nonconforming product from suppliers, in-process and final product with the\\nfollowing criteria and/or noteworthy points:\\n      that does not conform to specified requirements\\n      nonconforming issues address the identification, documentation, evaluation,\\n      segregation, and disposition of nonconforming product, including a determination of the\\n      need for an investigation and notification of the persons or organizations responsible for\\n      the nonconformance\\n      nonconformities are reviewed and achieve disposition and are documented\\n      responsibility for review and the authority for the disposition of nonconforming product is\\n      defined\\n      documentation includes the justification for use of nonconforming product and the\\n      signature of the individual(s) authorizing the use\\n      rework procedures exist and include retesting and reevaluation of the nonconforming\\n      product to insure that the product meets its current approved specifications; these\\n      activities are documented\\n      documentation within the DHR will apply to all medical devices\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":2771,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"IxRawTGiEjBSMy5uCh2qKZOH1hiYMOSLkv9CNh36ZW0=\"}","__type__":"TEXT"},"bc4159dd-6fb7-4b6e-b739-152fe2023fe8":{"__data__":"{\"id_\":\"bc4159dd-6fb7-4b6e-b739-152fe2023fe8\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_25\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"phIXP7BM4DAv/r8PbsuUZaq5AlHKPLvcIr4uG44nvGk=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        25       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nProcedures are implemented to insure that products that do not conform to specified\\nrequirements are prevented from unintended use. These procedures provide identification,\\ndocumentation, evaluation, segregation and disposition of nonconforming product.\\nCGL Quality Systems’ is responsible for the disposition of nonconforming product. Purchased in\\nprocess and final inspection components, assemblies and / or devices are subject to test and\\ninspection according to applicable procedures as documented in the applicable procedures.\\nDepartment Supervisors will identify and segregate nonconforming product for disposition by\\nthe Process Owner for Quality Systems. If nonconforming product is found during production\\nprocessing, a decision concerning product disposition is then made. Upon determination of\\nstatus, a rejection/corrective action request is issued and one of the following occurs:\\n      units are re-worked to meet the specified requirements\\n      units are accepted by concession with the customer\\n      units are reviewed for concessions with the customer\\n      units are rejected by using the concession tool (with the customer)\\n      units are rejected or scrapped by CGL\\nWhere required by the contract, the proposed use or repair of product that does not conform\\nto the specified requirements will be reported to the customer. Records are kept describing the\\nnonconformity which has been accepted, including any repairs for denoting the actual\\ncondition.\\nRe-inspection will occur for all repaired and/or re-worked product in accordance with\\napplicable procedures and specifications.\\nAnalysis of Data\\nIn an effort to drive improvement efforts within CGL, the data that is accumulated through\\ninternal monitoring of processes and other sources, which may include but not limited to:\\n      surveys\\n      internal evaluations\\n      customer focus surveys\\n      customer complaints and feedback\\n      marketing department input\\n      third party audits\\nThe data that is accumulated will be relevant to continual improvement as it relates to\\ncustomer satisfaction and/or dissatisfaction, conformance or customer requirements,\\ncharacteristics of processes, product and trends and suppliers.\\nImprovement and\\nContinual Improvement\\nIt is the intention of CGL that continual improvement to the QMS shall occur regularly and\\nfrequently, but not necessarily without interruption. When opportunities for improvement are\\nrealized, they will be prioritized focusing on the ones that will produce the greatest return on\\ninvestment. These activities will be delineated and facilitated via the Process Owner of Quality\\nSystems.\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":2849,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"IM4p/kYl7AAQf+1LDx8Etocj/3iahmW/ioS3Ds8zRhE=\"}","__type__":"TEXT"},"8c635bc4-f816-4b8e-854c-1c78b7184a79":{"__data__":"{\"id_\":\"8c635bc4-f816-4b8e-854c-1c78b7184a79\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_26\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"MSpA+4qB9zv9lMNbB//LwF0CDZXhJDncYxjijrBwMqU=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        26       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\nTo facilitate a well-rounded continual improvement effort, the focus will not be centered on the\\nnonconformance identified with the system, but rather inclusive of, and not necessarily\\nsimultaneously, the following areas:\\n      quality policy\\n      quality objectives\\n      analysis of data\\n      management reviews\\n      corrective and preventive actions\\n      internal audit results\\n      employee suggestions\\nCorrective Action CGL Procedure 820100\\nCGL has established documented procedures for the implementation of corrective action.\\nQuality Systems evaluates discrepant inspected product or process and determines lot\\ndisposition, effectiveness and corrective action, respectively. Procedures for corrective action\\ninclude, but not limited to:\\n      the effective handling of customer complaints and reports of product nonconformities\\n      investigation and documentation of the cause of nonconformities relating to product,\\n      process and the quality system)\\n      determination of the corrective action needed to eliminate the cause of\\n      nonconformities,\\n      application of controls to insure that effective corrective action is taken\\nManagement review sessions conducted in accordance with QMS will be used to evaluate the\\nneeds for corrective and preventive action through the analysis of various system measurement\\nresources and may include, but not limited to:\\n      customer return records\\n      customer product complaints\\n      supplier corrective actions\\n      corrective action reports that deal with detected nonconformities relating to products,\\n      processes and the QMS\\n      purchasing (supplier) history\\n      customer quality/delivery reports\\n      process control deviations\\nPreventive Action\\nCGL has established documented procedures for the implementation of preventive action.\\nProcedures for preventive action include, but not limited to:\\n   The use of information, such as processes and work instructions which affect product quality,\\n   concessions, audit results, quality records and customer complaints, to detect, analyze and\\n   eliminate potential causes of nonconformities.\\n   Determination of the steps needed to deal with any problems requiring preventive action,\\n   Initiation of preventive action and application of effective controls,\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":2508,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"yOPZvXOpXrWikajBjBDPTtRC+qOENhDFeCKzMdEiXGM=\"}","__type__":"TEXT"},"12b25948-20fa-4eb4-a4f8-a23f6b141528":{"__data__":"{\"id_\":\"12b25948-20fa-4eb4-a4f8-a23f6b141528\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_27\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf\",\"file_name\":\"82005.pdf\"},\"hash\":\"z/5V+w1LLZi27vP01yhtaGJdQYNob3weqSTz4vup1jY=\"}},\"text\":\"CG LABORATORIES, Inc. (CGL)\\n Document No.:       82005         Revision:    M         Page:        27       of       27\\n Title:               Quality Manual – ISO 13485: 2003 and 21 CFR, Part 820\\n   Insurance that relevant information on action taken is submitted for management review\\n   Sources of information that may be analyzed in order to detect and eliminate potential\\n   causes of nonconformities include, but not limited to:\\n      nonconformity records\\n      inspection and test records\\n      process monitoring results\\n      audit observations\\n      results of customer satisfaction surveys\\n      customer complaints/records\\n      regulatory authority or customer observations\\n      observations and reports by personnel\\n      sub-contractor problems\\nStatistical Techniques CGL Procedure 820250\\nCGL will establish and maintain procedures for identifying valid statistical techniques required for\\nestablishing, controlling and verifying the acceptability of process capability and product\\ncharacteristics. Sampling plans shall be written and base on ANSI Z 1.4 logic and rationale. CGL\\nwill make sure that these sampling methods are adequate for their intended use and ensure\\nthat when changes occur the sampling plans are reviewed and revised accordingly.    These\\nactivities shall be documented.\",\"textTemplate\":\"\",\"startCharIdx\":27,\"endCharIdx\":1333,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"G1BjycWOaXUO2GHKp1l/MCKVPmiBGu5DTchuTxMODII=\"}","__type__":"TEXT"},"3c3eb644-4f91-4019-b3eb-24911fb08782":{"__data__":"{\"id_\":\"3c3eb644-4f91-4019-b3eb-24911fb08782\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_1\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"IvZj5JOObagxgN7HAcAOjctaNNZ+5Cn3PNRO5yHVDTk=\"}},\"text\":\"QUALITY AGREEMENT\\n                                      Between\\n                                        And\\n                                 C&G Laboratories\\n                               1410 Southtown Drive\\n                              Granbury, Texas 76048\\n                          Issue date:\\nRevision History\\nAmendment         Detail of Change                                          Date\\nn/a               Original issue\",\"textTemplate\":\"\",\"startCharIdx\":30,\"endCharIdx\":460,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"AOyDCgPGflpr2VRrRNHWPhKx/j0GK/BVrCOyyYBPUN0=\"}","__type__":"TEXT"},"eba9a236-312f-44bf-a599-9a0e955cbfbf":{"__data__":"{\"id_\":\"eba9a236-312f-44bf-a599-9a0e955cbfbf\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_2\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"Vf1PlAsH4Gbxk0u+9PC2Y+eadBudvQ/0zVPXQ49/ojg=\"}},\"text\":\"QUALITY AGREEMENT APPROVALS:\\n(Quality Agreements between I sites require the approval of the site manager, QA and RA)\\nI Austin\\nQuality Assurance\\n Name                                             Title\\n Signature                                        Date\\nRegulatory Affairs\\n Name                                             Title\\n Signature                                        Date\\nSite / Plant Manager\\n Name                                             Title\\n Signature                                        Date\\nI LifeSciences Corporate Office\\nCorporate QA (if required)\\n N/A                                              N/A\\n Name                                             Title\\n N/A                                              N/A\\n Signature                                        Date\\n                                     Page 2 of 12\",\"textTemplate\":\"\",\"endCharIdx\":845,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"2M4Sg33/XUIazR1oH8mOHzqD/DNBdny+wvdq8EVe0zY=\"}","__type__":"TEXT"},"6ba6e8d6-ba64-4311-a4f4-175cd2ad7dcd":{"__data__":"{\"id_\":\"6ba6e8d6-ba64-4311-a4f4-175cd2ad7dcd\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_3\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"z6g2DpW1yntwPeAV7Rm/viS3uYvt2gINoeA14mdWVlE=\"}},\"text\":\"CG Labs (Granbury, Texas)\\nQuality Assurance\\n Name                                             Title\\n Signature                                        Date\\nRegulatory Affairs\\n Name                                             Title\\n Signature                                        Date\\nSite / Plant Manager\\n Name                                             Title\\n Signature                                        Date\\n                                     Page 3 of 12\",\"textTemplate\":\"\",\"endCharIdx\":466,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"4tWqjododN8Gty5dkea3nVI4C4shcug7CPgCz8JIgqs=\"}","__type__":"TEXT"},"17bb435f-0cca-42ae-aadf-4aaaf21fad0c":{"__data__":"{\"id_\":\"17bb435f-0cca-42ae-aadf-4aaaf21fad0c\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_4\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"69xXXE4dn3qZLoBf4EEtAh5mKxHQK1gPOEOeqJe+THw=\"}},\"text\":\"1.  PURPOSE\\n    The purpose of the Quality Agreement is to clearly outline key responsibilities for communication,\\n    controls, and quality assurance measures that must be established for both      I LifeSciences Austin and\\n    C&G Laboratories located at 1410 SouthTown Dr. Granbury Texas 76048. This Quality Agreement will\\n    ensure that products are manufactured according to agreed-upon specifications and Quality System\\n    requirements.\\n    C&G Labs is responsible for cleaning/ decontamination devices manufactured by          I LifeSciences and\\n    providing consultation services in matter of sterilization and cleaning of medical devices.\\n    This Quality Agreement is entered into and made effective upon the date of its signature by all\\n    approvers.\\n    Approval of this Quality Agreement will ensure that products are provided according to specifications\\n    and that products comply with applicable FDA Quality System Regulations, cGMPs, EN ISO 13485,\\n    the  Canadian  Medical  Device  Requirements   (CMDR),   the Medical  Directive (93/42/EEC           plus\\n    amendments), any other applicable regulations, product specifications and company policies and\\n    procedures as applicable.\\n2.  SCOPE\\n    This agreement is applicable to all products that are cleaned / decontaminated at C&G Labs. C& G\\n    labs Granbury facility is responsible for cleaning / decontamination of products that are returned from I\\n    customers (Surgeons, Hospitals, Surgery Centers, Distributors, and Global Distribution Centers etc.)\\n    Or from one of the I’s facility.\\n3.  QUALITY AGREEMENT REVIEW ANDMAINTENANCE\\n    It is the responsibility of the site Manager of QA (or delegate) to ensure that this agreement is reviewed\\n    annually. Modifications shall be made as required following the current change control procedure at the\\n    Site and approved by the same functions that signed the original agreement. Management at both\\n    facilities shall communicate any information in case of discrepancy, issues, changes related to the\\n    requirements described hereafter.\\n4.  RESPONSIBILITIES\\n    The Manager of Quality Assurance for        I LifeSciences Austin and the designated representative(s) at\\n    C&G labs at Texas site is responsible for ensuring that this Quality Agreement is properly executed.\\n5.  QA CONTACTS\\n    I Austin                                   C&G Labs\\n    Vishwas Sharma                                    Briana Monroe\\n    Sr Manager, Supplier Quality Management           Quality Assurance Manager\\n    +1-(512)-852-3945                                 +1-817-279-1945\\n    vishwas.sharma@Ilife.com                   bmonroe@cg-labs.com\\n6.  DEFINITIONS\\n    I site - refers to the I LifeSciences site who is the design control owner.\\n    Supplier - refers C&G laboratories Texas, that is providing the finished products\\n    Nonconforming product - refers to a product that does not fulfil of a specified requirement.\\n    Complaint  - refers to any written, electronic or oral communication that alleges deficiencies related to\\n    the identity, quality, durability, reliability, safety, efficiency, or performance of a device after its release\\n    for distribution.\\n                                         Page 4 of 12\",\"textTemplate\":\"\",\"endCharIdx\":3250,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"OhGU6gXmDEhu/uIdmN8/sqIyHbfV58Yv+JNZZc9hXa4=\"}","__type__":"TEXT"},"c8569f7c-7da0-4f33-a38d-9d4b7d8b892e":{"__data__":"{\"id_\":\"c8569f7c-7da0-4f33-a38d-9d4b7d8b892e\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_5\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"KbGFgJd8yMW5tFA8tufdgcwNzWF38dHAtrw6EJElj6g=\"}},\"text\":\"Recall -          refers to the removal or correction of a marketed product that the Competent Authority\\n    considers to be non-conforming with standards and against which the agency could initiate actions.\\n7.  MANAGEMENT RESPONSIBILITY\\n    The Vice President/Quality Leader at Supplier and    I are responsible for quality planning and assuring\\n    that resources are dedicated to achieve requirements of regulatory agencies and customers.\\n8.  QUALITY AUDITS\\n    Both parties are responsible for having an internal and supplier audit program in place. Based on the\\n    existing EU Medical Device Directive (93/42/EEC, as amended), Notified Bodies have the authority to\\n    perform unannounced audits. To verify day-to-day compliance to legal requirements,   I’s Notified Bodies\\n    may determine it is necessary to visit the site of a critical component or finished device manufacturer\\n    without prior notice. If you choose to deny access to a Notified Body’s audit team, please notify      I\\n    immediately. Your cooperation, if an unannounced visit should occur, it sincerely appreciated. Supplier\\n    shall allow the I Notified Body and the Competent Authority of      I to examine technical documentation\\n    held by C&G labs site for products specifically supplied to I.\\n9.  QUALITY SYSTEM /REGULATORY COMPLIANCE\\n    C&G labs shall notify   I within twenty-four (24) hours of receipt of contact from the FDA, ISO Notified\\n    Body, or any other regulatory agency if such entity contacts C&G labs to investigate or inspect its\\n    facilities with respect to the Products or manufacturing records of the Products provided to I and notify\\n    I of any applicable findings or corrective actions related to their Product. C&G labs will immediately\\n    notify I of any regulatory action taken against C&G labs that would affect product availability or bring\\n    into question the quality and safety of the Products sourced by I.\\n    I shall notify C&G labs within twenty-four (24) hours of any FDA, ISO or any other regulatory agency\\n    audit of I that is related to Products cleaned at C&G labs     site or services provided by C&G labs and\\n    notify C&G labs of any applicable findings or corrective actions related to the Products.   In addition,\\n    where a response or corrective action and preventive action are required,    I will submit a response to\\n    C&G labs for review prior to submission, as applicable.\\n10. Record Retention\\n    C&G labs shall retain all documentation generated during the manufacturing process as required by  I’s\\n    Standard Operating Procedures (hereinafter “SOPs”) and based on the expected life of the device, but\\n    no less than five (5) years from the date of release of the device for commercial distribution.  I shall\\n    retain      distribution     documentation        in      accordance        with      I’s          SOPs.\\n11. AGREEMENT MAINTENANCE\\n    This Quality Agreement may be reviewed as mutually agreed upon by the Parties. No amendment,\\n    modification or alteration to this Quality Agreement shall bind either Party unless made in writing and\\n    approved by both Parties.\\n    This Quality Agreement shall commence on the Effective Date and shall remain in effect for as long as\\n    C&G Labs supplies product to  I LifeSciences.\\n                                           Page 5 of 12\",\"textTemplate\":\"\",\"startCharIdx\":4,\"endCharIdx\":3352,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"YSxJxzZ3fzPfXmaCZqfGdzQlohsIgBMI+zrpw+nsCaw=\"}","__type__":"TEXT"},"60e1d517-d0b6-4e7a-a6bd-1ebbf9781712":{"__data__":"{\"id_\":\"60e1d517-d0b6-4e7a-a6bd-1ebbf9781712\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_6\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"uYyEnq+rbpjXMNhKJDFkE//0VdARB1OQ4GYbqe5ozmg=\"}},\"text\":\"QUALITY AGREEMENT REQUIREMENTS\\n              Duties                       I Austin     C&G Labs               Comments\\n                                            (Site)      (Supplier)\\n                                           Regulatory and Compliance\\n•   Follow applicable regulations\\n    and European Good\\n    Manufacturing Practices                X                X\\n    including Directive 93/42/EEC,\\n    as amended, and the U.S. FDA\\n    21 CFR 820\\n•   Any submission requirements\\n    (FDA, Notified Body, Health            X\\n    Canada, Government laws)\\n•   Technical Files                        X                          I will maintain the product\\n                                                                      technical files\\n                                                                      This will be led by the Site;\\n•   Product recall investigation           X                X         however, Supplier will provide\\n                                                                      support as requested.\\n                                                                      This will be led by the Site;\\n•   Product recall reporting               X                X         however, Supplier will provide\\n                                                                      support as requested\\n•   Establishment registration and                                    Both parties are responsible\\n    medical device listing with FDA        X                X         for maintaining Establishment\\n    and availability of registration                                  registration and medical\\n    registered form.                                                  device listing with FDA.\\n•   Facility registration with ISO         X                X         Supplier to be certified per ISO\\n    Notified Body.                                                    13485 and ISO 9001:2008, at\\n                                                                      minimum\\n                                                                      For example, moving to new\\n•   Notify I of key organizational                          X         facility, change in quality or\\n    and/or key personnel changes                                      operations management,\\n                                                                      acquisition or merger\\n•   Other Regulatory Requirements,\\n    e.g. radiation compliance, risk                                   N/A\\n    management file management\\n                                           Audit - Internal\\n•   Maintain internal Good\\n    Manufacturing Practices audit                           X\\n    program\\n•   Identify and implement corrective                       X\\n    actions to internal audits\\n                                                                      Significant findings that may\\n                                                                      affect product safety or\\n                                                                      efficacy shall be\\n•   Review of Audit report                                  X         communicated to the Site, by\\n                                                                      the Supplier’s QA Director,\\n                                                                      along with the plans for\\n                                                                      corrective action.\\n                                           Audit - External\\n                                           Page 6 of 12\",\"textTemplate\":\"\",\"startCharIdx\":43,\"endCharIdx\":3598,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"/+PY0u2jAZkS4JSMhLwUF/IAC1oGk0cseLSvHp6SGLU=\"}","__type__":"TEXT"},"8e9068b1-c25a-438f-9b6b-b1642e324961":{"__data__":"{\"id_\":\"8e9068b1-c25a-438f-9b6b-b1642e324961\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_7\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"cAK4pufBCeXG4op/G8SeN2ElzW47UFnAA5bywzPYmgM=\"}},\"text\":\"Duties                         I Austin     C&G Labs                Comments\\n                                               (Site)      (Supplier)\\n                                                                          Significant findings which may\\n                                                                          affect product safety or\\n•   Review of a Notified Body or                               X          efficacy shall be\\n    FDA Audit report                                                      communicated to the Site by\\n                                                                          Supplier QA Director or\\n                                                                          designee along with the plans\\n                                                                          for corrective action.\\n                                              Design Control\\n•   Maintenance and storage of                X\\n    DHF\\n                                                                          Supplier to maintain risk\\n                                                                          management file for the\\n•   Design activities including Risk          X                X          activities performed at their\\n    Management                                                            site. Supplier should perform\\n                                                                          risk management activities as\\n                                                                          per their internal procedures.\\n                                                                          Formal supplier approval is not\\n                                                                          necessary; however, any\\n                                                                          issues with the Supplier’s\\n                                                                          ability to meet design changes\\n                                                                          shall be communicated to the\\n•   Review of Design Changes                  X                X          Site.\\n                                                                          Any change to products\\n                                                                          specification processed at the\\n                                                                          supplier site will be\\n                                                                          communicated to the supplier\\n                                                                          by I immediately upon I’s\\n                                                                          approval.\\n                                              Change Control / Document control\\n                                                                          I will inform C&G of\\n•   Review and approval of                                                Engineering changes\\n    Engineering Change pertaining             X                           pertaining to products defined\\n    to products defined in the scope                                      in the scope of this quality\\n    section of this document                                              agreement, if it impacts any\\n                                                                          cleaning activities done at their\\n                                                                          site.\\n•   Review and approve Device                 X\\n    Master Records\\n                                                                          Notification to Site if quality\\n•   Review and approval of Supplier                            X          system changes affect\\n    Quality System documents                                              products in scope of this\\n                                                                          Quality Agreement including\\n                                                                          new certificates\\n•   Review and approve Device                 X                           Record UDI information for\\n    History Records                                                       each finished device.\\n•   Notify I of all changes to facility,                                  Supplier shall notify I of any\\n    process, equipment, test                                              change to manufacturing\\n    methods, quality systems and                               X          process that may affect I\\n    specifications that impact                                            products this includes changes\\n    Product identity, safety, purity,                                     to any cleaning/\\n    stability, regulatory status or\\n                                              Page 7 of 12\",\"textTemplate\":\"\",\"startCharIdx\":15,\"endCharIdx\":4889,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"nka/wYuMOLO9GtG6Ky9X9wWBXLkFW5eu1On2aKcfaO4=\"}","__type__":"TEXT"},"7d387da3-9158-4462-860e-2854f902cf0e":{"__data__":"{\"id_\":\"7d387da3-9158-4462-860e-2854f902cf0e\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_8\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"aSj/iD684bvAHjjLYIRosWeVqJfCcX+W8KwC9SrQIQQ=\"}},\"text\":\"Duties                      I Austin        C&G Labs                Comments\\n                                            (Site)         (Supplier)\\n    validation/qualification. Change                                      decontamination processes,\\n    control process should account                                        chemicals etc.\\n    for changes including, but not\\n    limited to facility, process, test\\n    methods, functionality, quality\\n    specifications and approved\\n    vendor, raw materials,\\n    component specifications.\\n•   Document all required process\\n    and testing steps at the time\\n    such process or testing step is           X                X\\n    executed, e.g. cleaning and\\n    packaging validation.\\n                            Product & Process Environment (If Applicable)\\n•   Manufacture, package, ship,\\n    store, and test the Product and\\n    materials in an environment\\n    meeting the applicable GMP\\n    regulations, which is designed,\\n    constructed and maintained in a\\n    manner that a) permits the                                 X\\n    operation therein to be\\n    performed under clean, sanitary\\n    and orderly conditions, b)\\n    prevents the contamination of\\n    the Product and the addition of\\n    extraneous material to the\\n    Product.\\n•   Refrain from activity that could          X                X\\n    adversely affect the Product.\\n•   If applicable, establish and\\n    maintain a program for\\n    environmental monitoring                                   X\\n    including tracking and trending\\n    processes.\\n•   Buildings and facilities used in\\n    the manufacture of the Product\\n    shall be designed, constructed\\n    and maintained to facilitate\\n    cleaning, maintenance and\\n    operations and to ensure orderly                           X\\n    placement of equipment and\\n    materials to prevent mix-ups and\\n    contamination as appropriate to\\n    the type and stage of\\n    manufacture.\\n•   Maintain and document an                  X                X\\n    adequate pest control program\\n                                           Page 8 of 12\",\"textTemplate\":\"\",\"startCharIdx\":15,\"endCharIdx\":2104,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"Ox6v94wU5y9M6lWncRuJBdz4zYAcpeyUk7580ow4x5Y=\"}","__type__":"TEXT"},"ac989ea6-27b2-4709-8f46-3d7b718086ab":{"__data__":"{\"id_\":\"ac989ea6-27b2-4709-8f46-3d7b718086ab\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_9\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"iHWz8LyInIWUJLu2CsFmcTMYe23HFoBJAg/fQfnRnqg=\"}},\"text\":\"Duties                        I Austin     C&G Labs                Comments\\n                                              (Site)      (Supplier)\\n                                                                        Supplier shall establish\\n                                                                        documented requirements for\\n•   Work Environment                                          X         health, cleanliness, and\\n                                                                        clothing for personnel involved\\n                                                                        in the manufacture of the\\n                                                                        Product\\n                                             Sterilization (If applicable)\\n                                                                        C&G labs will be responsible\\n                                                                        for validation/ revalidation of\\n•   Validation/ revalidation                 X                X         Cleaning, sterilization activities\\n                                                                        that C&G performs for I\\n                                                                        products.\\n                                             Product Release\\n•   Retains                                  X\\n                                                                        Should be done as per\\n•   Finished Goods Shipment                                   X         supplier Internal packaging /\\n                                                                        shipping procedures.\\n                                             Nonconforming Product & Out of Specification Tests\\n•   Have appropriate procedures for                                     All non-conformances are  to\\n    identification, investigation,           X                X         be handled by I and the\\n    reporting, tracking, trending and                                   supplier as per their Quality\\n    closure of deviations.                                              System.\\n•   Segregation, evaluation, and                                        All non-conformances are  to\\n    disposition of non-conforming            X                X         be handled by supplier and I\\n    product                                                             under their Quality System.\\n                                                                        Notify I within 3 business days\\n•   Approval of concession to use            X                X         of any deviation or out-of-\\n    out-of-specification material                                       specification situation affecting\\n                                                                        the quality of the Product.\\n•   Trending of nonconforming\\n    material                                 X                X         As per procedure\\n•   Provide investigation\\n    documentations to I upon                                  X\\n    request\\n•   Complete investigations within\\n    thirty (30) days of\\n    commencement. Supplier shall             X                X\\n    notify I in writing if investigations\\n    will extend beyond the original\\n    thirty (30) days.\\n•   Complete corrective action\\n    commitments resulting from               X                X\\n    investigations or complaints\\n    within the planned timeframe.\\n                                             Page 9 of 12\",\"textTemplate\":\"\",\"startCharIdx\":15,\"endCharIdx\":3548,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"8srcqOS1BVZHGVEQH9AZC2ZGLbW9GNP6NS9vpD52NMA=\"}","__type__":"TEXT"},"c2eba848-5efa-431c-b51e-03f7c6c6cc8b":{"__data__":"{\"id_\":\"c2eba848-5efa-431c-b51e-03f7c6c6cc8b\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_10\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"sT5xOYr6cVbQtd1bRaXl2ge0yRvHsETlxeZ0sLXjt3M=\"}},\"text\":\"Duties                        I Austin    C&G Labs                Comments\\n                                             (Site)     (Supplier)\\n•   Have a rework procedure for\\n    Product requiring rework\\n    describing the rationale and\\n    justification for the rework                                       Rework or Retesting\\n    processes. Rework is a                                   X         procedures require review and\\n    manufacturing step involving a                                     approval by I\\n    technique or technology that is\\n    not a part of the approved\\n    process sequence.\\n•   For any product that is reworked,\\n    record of rework is to be                                X\\n    provided to Site.\\n                                                                       I and Supplier are responsible\\n                                                                       for having a quarantine\\n•   Quarantine Procedure                    X                X         procedure and work flows as\\n                                                                       applicable during their control\\n                                                                       of the product.\\n                                            Product Complaints\\n•   Maintained finished device              X\\n    complaint files\\n                                                                       Customer complaint returns\\n•   Testing or evaluation of                X                X         may be accompanied with a\\n    complaint samples                                                  Supplier Corrective Action\\n                                                                       Request (SCAR)\\n•   Investigation of complaint root         X                X         Site may need to be involved\\n    cause                                                              when design issues are\\n                                                                       encountered\\n•   Implementation and verification         X                X         Site may need to be involved\\n    of Corrective Action Taken                                         when design issues are\\n                                                                       encountered\\n•   Complaint trending and reporting        X\\n•   Submissions of\\n    MDR/MDV/Canadian/other                  X\\n    Mandatory Reporting\\n                                            Qualification and Training\\n•   Provide sufficient training to\\n    meet obligations of this quality        X                X\\n    agreement\\n•   Only persons with the necessary\\n    awareness, skills, competence\\n    and training shall be assigned          X                X\\n    responsibilities in the product\\n    associated with this agreement.\\n•   Provide adequate number of\\n    personnel qualified by\\n    appropriate training and\\n    experience to perform and               X                X\\n    supervise the manufacture,\\n    testing, packaging and\\n    disposition of the Product.\\n                                            Page 10 of 12\",\"textTemplate\":\"\",\"startCharIdx\":14,\"endCharIdx\":3107,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"B+5B/RpsY5QYBSFNhaOYQqgVcOoPVdwEu5DURrV/R+Q=\"}","__type__":"TEXT"},"4e8a5d32-0260-4a43-93a2-337edfd6bbad":{"__data__":"{\"id_\":\"4e8a5d32-0260-4a43-93a2-337edfd6bbad\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_11\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"BwHhsD7hqZHnlGTSuqhJIyLQXUzu1v9UXwlPBxMXnZY=\"}},\"text\":\"Duties                     I Austin        C&G Labs                Comments\\n                                           (Site)         (Supplier)\\n                                     Visits to Manufacturing Sites\\n•   Supplier to allow Site to visit\\n    facility(s) to review any activities     X                 X         This includes Supplier Quality\\n    pertaining to this quality                                           Audits.\\n    agreement.\\n•   Supplier to allow I Notified Body        X                 X\\n    to conduct unannounced audits\\n                                         Purchasing Controls\\n•   Supplier shall acknowledge all                             X\\n    purchase orders within 5 days\\n•   Have approved written\\n    procedures in place for\\n    qualification (including audits) of                        X\\n    suppliers that provide GMP-\\n    materials and services.\\n                                  Production and Process Controls\\n                                                                         Supplier shall ensure that any\\n                                                                         outsourced processes that\\n•   Sub-contractor validations                                 X         cannot be 100% verified, are\\n                                                                         validated by the sub-\\n                                                                         contractor.\\n•   System to ensure the proper\\n    identification and traceability\\n    during handling, storage and                               X         Products shall be traceability\\n    distribution (Product                                                by lot number/batch\\n    Classification dependent) of\\n    Product\\n•   Maintain calibrations and\\n    preventive maintenance\\n    procedures and schedules for\\n    equipment/instruments used in\\n    the manufacture, packaging,                                X\\n    testing and validation/verification\\n    of the Product. Include\\n    calibration tagging where\\n    appropriate.\\n•   Requirements for Certificates of                           X\\n    Analysis / Conformance\\n•   Document and review (including\\n    calibrations performed by Sub-\\n    Contractor) manufacturing                                  X\\n    equipment calibration data and\\n    make available to I for onsite\\n    review upon request\\n•   Implement and document\\n    specifications for raw materials,\\n    packaging materials, Product                               X\\n    labeling, and processing aids\\n    that would likely affect Product\\n    quality.\\n                                          Page 11 of 12\",\"textTemplate\":\"\",\"startCharIdx\":15,\"endCharIdx\":2656,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"YEPmsQS3i94mSjjC4wBjMBlZAr1EnrVdaPMmbbgpHeo=\"}","__type__":"TEXT"},"72be6c3e-2b6e-42d9-8512-b68f3837a87f":{"__data__":"{\"id_\":\"72be6c3e-2b6e-42d9-8512-b68f3837a87f\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"excludedEmbedMetadataKeys\":[],\"excludedLlmMetadataKeys\":[],\"relationships\":{\"SOURCE\":{\"nodeId\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_12\",\"metadata\":{\"file_path\":\"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\",\"file_name\":\"GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf\"},\"hash\":\"AmPQdw1rVstWly/C7DibK8T9PxTY/mBAggb9vOxdSLQ=\"}},\"text\":\"Duties                     I Austin        C&G Labs               Comments\\n                                          (Site)         (Supplier)\\n•   Have approved written\\n    procedures for all required in-                          X\\n    process sampling and testing.\\n•   Process equipment must be\\n    uniquely identified, status tagged\\n    and managed with an equipment                            X\\n    history log or equivalent system.\\n    Process lines will be\\n    appropriately identified.\\n•   Validated/qualify as necessary\\n    all critical systems, utilities and\\n    equipment/instruments used for\\n    the manufacture and control of                           X\\n    Product (Installation Qualification\\n    (IQ), Operational Qualifications\\n    (OQ), and/or Performance\\n    Qualification (PQ)).\\n•   Maintain shipping records                                X\\n                                        Page 12 of 12\",\"textTemplate\":\"\",\"startCharIdx\":14,\"endCharIdx\":926,\"metadataSeparator\":\"\\n\",\"type\":\"TEXT\",\"hash\":\"6+Xstv3BdofKVa0hAUvj+gXZ6tF/8nsj/4ueTsRu5/g=\"}","__type__":"TEXT"}},"docstore/metadata":{"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_1":{"docHash":"XkUvjhfBLbDIA7i1VcxsaIgv28DigHEgaKr8nDMDwMg="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_2":{"docHash":"Z8ftV1u05KqnnGwCqSgHFaTNGN+wECJbOoPPt0ZZErg="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_3":{"docHash":"2Ln5qOVHzj5dSSwXzPYIUFoFix+yECaHYVltsNW9RVU="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_4":{"docHash":"a1ZvYlGeyQvz2oR1WXfTL+7kclTKsoQFpxyh61j+zFI="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_5":{"docHash":"lIZk1N4Zv40b3A2zAmGDLjDyezxtj3exiDcmqt7yhCo="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_6":{"docHash":"nTu98s1aqLCGLy7mF81ARmjer2sMV5ZVtZil5rxiI60="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_7":{"docHash":"5pU3KtgFvIoHi0BS7g2cbBanmg34jO8uYgo1CtwT4A0="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_8":{"docHash":"4WauzTZ+Ve7jxXdR5OqprOcdNvcNJackqJJMkZxBT1A="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_9":{"docHash":"OU2h2MEGpHOJij4pI7NoKFqFXpoUprBqPYJsJpWRCgE="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_10":{"docHash":"Cm1ihZHp3CPbNNKXMD0daSjkuQJoE/6jlrrIgYc78qI="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_11":{"docHash":"kmfdKjIHTxM/RQeSOV3kTfDyKQtXL+aRjg9yFQ148ZA="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_12":{"docHash":"d2hX49SlMEfhygENWrM2exyJE5PJ5HDEjrS6a3Veaw4="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_13":{"docHash":"YKDa17z6h0AOYRkk5wjGtD12NeRfukftYvgFIjLJ6ic="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_14":{"docHash":"bZWDyESHUEmr1Ai3vFL2WY/ysXhXsllA28ZkrMuqPks="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_15":{"docHash":"01orx0SuNjvDUyCzCGf9q3Q9Fa26qSSZvIRwjZlqGA0="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_16":{"docHash":"tx9yHl95ys5XSxHiCJMMSY0WfkCWyNJkylo7jaRaUGM="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_17":{"docHash":"r5sFvFWbJ+90IL2COULgJ/gtshucMNRJz/bFFc9xp1g="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_18":{"docHash":"ylxWhPyOajP03cTqxykW1DK9ZJytvqgmzspLfKldm58="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_19":{"docHash":"c8QPaPuYzbePsKGyu/S/8xpXT0Omhc35QPJGf3AXy18="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_20":{"docHash":"gjf7wuHcBUd2H8mBgWPhyoKVVTpmLdowsy3M1wWw/fU="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_21":{"docHash":"4X44Ue2w5o1UM5RyCopu1LjD+qFySrKLm2iA3ZNxjUs="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_22":{"docHash":"yQPt1z5zRmo02av2J9wGqbRwf4Vw+X+4grfzserw2Ks="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_23":{"docHash":"A3hKm8ahkG2cUbKMDvZBuaN62KlDsPwH58GE2EoAc2w="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_24":{"docHash":"cFaPXimwr+r99srRXe0kBssxFau/+3kqflKFrUD0H+M="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_25":{"docHash":"phIXP7BM4DAv/r8PbsuUZaq5AlHKPLvcIr4uG44nvGk="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_26":{"docHash":"MSpA+4qB9zv9lMNbB//LwF0CDZXhJDncYxjijrBwMqU="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_27":{"docHash":"z/5V+w1LLZi27vP01yhtaGJdQYNob3weqSTz4vup1jY="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_1":{"docHash":"IvZj5JOObagxgN7HAcAOjctaNNZ+5Cn3PNRO5yHVDTk="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_2":{"docHash":"Vf1PlAsH4Gbxk0u+9PC2Y+eadBudvQ/0zVPXQ49/ojg="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_3":{"docHash":"z6g2DpW1yntwPeAV7Rm/viS3uYvt2gINoeA14mdWVlE="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_4":{"docHash":"69xXXE4dn3qZLoBf4EEtAh5mKxHQK1gPOEOeqJe+THw="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_5":{"docHash":"KbGFgJd8yMW5tFA8tufdgcwNzWF38dHAtrw6EJElj6g="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_6":{"docHash":"uYyEnq+rbpjXMNhKJDFkE//0VdARB1OQ4GYbqe5ozmg="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_7":{"docHash":"cAK4pufBCeXG4op/G8SeN2ElzW47UFnAA5bywzPYmgM="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_8":{"docHash":"aSj/iD684bvAHjjLYIRosWeVqJfCcX+W8KwC9SrQIQQ="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_9":{"docHash":"iHWz8LyInIWUJLu2CsFmcTMYe23HFoBJAg/fQfnRnqg="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_10":{"docHash":"sT5xOYr6cVbQtd1bRaXl2ge0yRvHsETlxeZ0sLXjt3M="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_11":{"docHash":"BwHhsD7hqZHnlGTSuqhJIyLQXUzu1v9UXwlPBxMXnZY="},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_12":{"docHash":"AmPQdw1rVstWly/C7DibK8T9PxTY/mBAggb9vOxdSLQ="},"94316b45-2459-489a-8b78-bef765de5be4":{"docHash":"HE0GTSxdmmkZcI4UWeSDdnQln+rK2bWt4rGSuWptRWk=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_1"},"3b89a086-b28e-408d-bee0-e6da804444ef":{"docHash":"9UI4zo6vbzLOg/ZQ65Y9LR1KEFJt6VQjNcLF6CN6WVc=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_2"},"f189b81f-c2a9-414b-a3aa-cbe784d16d67":{"docHash":"j6w6X67BRXOroNKZO1jKIk3cPOIPFk8du7VZOKlQZNQ=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_3"},"905459cf-c792-4ff5-b441-8c2dd03b502c":{"docHash":"M9h3Ad+xWuIsYbYZM1AjbKJBRpWmUaNxYKjr6q2VitU=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_4"},"9db29b0a-68b6-4640-97d5-ae22de5b239f":{"docHash":"tlgBLjCC58XQ/w4pLjySH7FJsYMGLl5RRpPCeWUAXBY=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_5"},"217c4f3b-2d2d-4c7a-b052-c0f051373038":{"docHash":"7kzP1hsKYb+W+YNqpR5LlqV56bPCP6j4Jp+CzzBlGTs=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_6"},"34848cea-8795-46ff-ae1a-da1bfe545366":{"docHash":"RS8fTZYA1ny+UKV7O8Q97POT6/WU1LucMosoXhkRmfQ=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_7"},"2ccb6209-4de4-4327-a328-8eb895a4b6f2":{"docHash":"bPx4hfCjsAGZbcCsj7FBEWzdTNTvrQ80qOw1wUBPVt8=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_8"},"0d9c4de6-3547-40f4-b5c4-b19afb4959d6":{"docHash":"Dc8QoSngO1pX5t3XqUS3lUrd0G7GFiT/Y+KNpV+vlzg=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_9"},"5683575c-685b-4705-b81f-bf2ee20a9dc6":{"docHash":"Cbz+s2I7/LIaojXZThGWi3TpCyamNz2klQwnUGc6IE0=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_10"},"507b68f1-d7f4-4172-9591-3675f41318ff":{"docHash":"KBcNzBPXQkZIUv9TUOlHODlMLvIrywIjf3+fKM/hG/o=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_11"},"05693ea2-2916-46ae-9d99-ab995ff80e6f":{"docHash":"Ldwnp04bYKyE41F43Y/5n8OweDabdwKdAd4Fxo/B9KY=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_12"},"ca4adf06-be37-4ac9-907d-d639c8e87e2f":{"docHash":"sMgaj85dwseVIR1pW3WKq8oCdflTCXWudMS/+8Wj1UQ=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_13"},"d17e4b4a-d77e-49ca-9738-c830b7887942":{"docHash":"uXK2SoizNqXGe33BXQQO2g77RMPrZmC1xxl6NX+/Bpc=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_14"},"1fd02afd-deae-4a6c-93ec-71bcf6b0e120":{"docHash":"Y/+8yZ8CDRB138DaFBLwGjjQhMf7cXR14iLIkiowe+w=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_15"},"83b4fd1f-af3a-4f61-8e76-e9107112f8e4":{"docHash":"CumrZou1BR9uYBtueKCN3qMxUdKAGvMID3V4tMtknBA=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_16"},"8435bed3-e5f6-4ac0-b9af-b9387e0d4cb7":{"docHash":"mVA/EjLe4GJZMzXJkp5TbjE0kL8ugnpABmqy+GAigno=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_17"},"175c55bf-34ae-481a-9a9f-04aab46452ce":{"docHash":"MwkLumjud957HcSeVuirjiUz/rOjfpGjuzutEI6raX4=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_18"},"5c0d9550-26cc-4b88-b04d-e28182397ef5":{"docHash":"nszEm5EyRnCilsSjgd3GaYW5yRrBbg/FaSAQGzRLYpA=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_19"},"be680354-79b2-4856-ad09-c6aec348aa66":{"docHash":"ftOhCNVDy53UgHkfk1j0Q0LEbxzKdO5EyZrxtwJp/WQ=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_20"},"dd56c4be-91ca-445a-af45-822891aba1aa":{"docHash":"vpfiwhEED9F5RuE+YKUF0IjgcOpnB1mHQ5x+I4lShzo=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_21"},"f2a9b181-8a3b-4d5b-a3b7-a788368c1858":{"docHash":"Bl/vs5PsHdQp7pet0xGP7ffTp1yuMPJcFlHSWzCq3tY=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_22"},"6b386c8c-74ba-4bf6-a1d5-34e9b85f7805":{"docHash":"Gg9PenzynB/8Mn/qBtA9kYftZAq/fOv6MmCxJiU5hyA=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_23"},"7b0b191a-c225-4309-8c80-0b08ef75df8e":{"docHash":"IxRawTGiEjBSMy5uCh2qKZOH1hiYMOSLkv9CNh36ZW0=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_24"},"bc4159dd-6fb7-4b6e-b739-152fe2023fe8":{"docHash":"IM4p/kYl7AAQf+1LDx8Etocj/3iahmW/ioS3Ds8zRhE=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_25"},"8c635bc4-f816-4b8e-854c-1c78b7184a79":{"docHash":"yOPZvXOpXrWikajBjBDPTtRC+qOENhDFeCKzMdEiXGM=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_26"},"12b25948-20fa-4eb4-a4f8-a23f6b141528":{"docHash":"G1BjycWOaXUO2GHKp1l/MCKVPmiBGu5DTchuTxMODII=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_27"},"3c3eb644-4f91-4019-b3eb-24911fb08782":{"docHash":"AOyDCgPGflpr2VRrRNHWPhKx/j0GK/BVrCOyyYBPUN0=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_1"},"eba9a236-312f-44bf-a599-9a0e955cbfbf":{"docHash":"2M4Sg33/XUIazR1oH8mOHzqD/DNBdny+wvdq8EVe0zY=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_2"},"6ba6e8d6-ba64-4311-a4f4-175cd2ad7dcd":{"docHash":"4tWqjododN8Gty5dkea3nVI4C4shcug7CPgCz8JIgqs=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_3"},"17bb435f-0cca-42ae-aadf-4aaaf21fad0c":{"docHash":"OhGU6gXmDEhu/uIdmN8/sqIyHbfV58Yv+JNZZc9hXa4=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_4"},"c8569f7c-7da0-4f33-a38d-9d4b7d8b892e":{"docHash":"YSxJxzZ3fzPfXmaCZqfGdzQlohsIgBMI+zrpw+nsCaw=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_5"},"60e1d517-d0b6-4e7a-a6bd-1ebbf9781712":{"docHash":"/+PY0u2jAZkS4JSMhLwUF/IAC1oGk0cseLSvHp6SGLU=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_6"},"8e9068b1-c25a-438f-9b6b-b1642e324961":{"docHash":"nka/wYuMOLO9GtG6Ky9X9wWBXLkFW5eu1On2aKcfaO4=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_7"},"7d387da3-9158-4462-860e-2854f902cf0e":{"docHash":"Ox6v94wU5y9M6lWncRuJBdz4zYAcpeyUk7580ow4x5Y=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_8"},"ac989ea6-27b2-4709-8f46-3d7b718086ab":{"docHash":"8srcqOS1BVZHGVEQH9AZC2ZGLbW9GNP6NS9vpD52NMA=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_9"},"c2eba848-5efa-431c-b51e-03f7c6c6cc8b":{"docHash":"B+5B/RpsY5QYBSFNhaOYQqgVcOoPVdwEu5DURrV/R+Q=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_10"},"4e8a5d32-0260-4a43-93a2-337edfd6bbad":{"docHash":"YEPmsQS3i94mSjjC4wBjMBlZAr1EnrVdaPMmbbgpHeo=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_11"},"72be6c3e-2b6e-42d9-8512-b68f3837a87f":{"docHash":"6+Xstv3BdofKVa0hAUvj+gXZ6tF/8nsj/4ueTsRu5/g=","refDocId":"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_12"}},"docstore/ref_doc_info":{"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_1":{"nodeIds":["94316b45-2459-489a-8b78-bef765de5be4"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_2":{"nodeIds":["3b89a086-b28e-408d-bee0-e6da804444ef"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_3":{"nodeIds":["f189b81f-c2a9-414b-a3aa-cbe784d16d67"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_4":{"nodeIds":["905459cf-c792-4ff5-b441-8c2dd03b502c"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_5":{"nodeIds":["9db29b0a-68b6-4640-97d5-ae22de5b239f"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_6":{"nodeIds":["217c4f3b-2d2d-4c7a-b052-c0f051373038"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_7":{"nodeIds":["34848cea-8795-46ff-ae1a-da1bfe545366"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_8":{"nodeIds":["2ccb6209-4de4-4327-a328-8eb895a4b6f2"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_9":{"nodeIds":["0d9c4de6-3547-40f4-b5c4-b19afb4959d6"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_10":{"nodeIds":["5683575c-685b-4705-b81f-bf2ee20a9dc6"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_11":{"nodeIds":["507b68f1-d7f4-4172-9591-3675f41318ff"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_12":{"nodeIds":["05693ea2-2916-46ae-9d99-ab995ff80e6f"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_13":{"nodeIds":["ca4adf06-be37-4ac9-907d-d639c8e87e2f"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_14":{"nodeIds":["d17e4b4a-d77e-49ca-9738-c830b7887942"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_15":{"nodeIds":["1fd02afd-deae-4a6c-93ec-71bcf6b0e120"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_16":{"nodeIds":["83b4fd1f-af3a-4f61-8e76-e9107112f8e4"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_17":{"nodeIds":["8435bed3-e5f6-4ac0-b9af-b9387e0d4cb7"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_18":{"nodeIds":["175c55bf-34ae-481a-9a9f-04aab46452ce"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_19":{"nodeIds":["5c0d9550-26cc-4b88-b04d-e28182397ef5"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_20":{"nodeIds":["be680354-79b2-4856-ad09-c6aec348aa66"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_21":{"nodeIds":["dd56c4be-91ca-445a-af45-822891aba1aa"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_22":{"nodeIds":["f2a9b181-8a3b-4d5b-a3b7-a788368c1858"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_23":{"nodeIds":["6b386c8c-74ba-4bf6-a1d5-34e9b85f7805"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_24":{"nodeIds":["7b0b191a-c225-4309-8c80-0b08ef75df8e"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_25":{"nodeIds":["bc4159dd-6fb7-4b6e-b739-152fe2023fe8"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_26":{"nodeIds":["8c635bc4-f816-4b8e-854c-1c78b7184a79"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/82005.pdf_27":{"nodeIds":["12b25948-20fa-4eb4-a4f8-a23f6b141528"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_1":{"nodeIds":["3c3eb644-4f91-4019-b3eb-24911fb08782"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_2":{"nodeIds":["eba9a236-312f-44bf-a599-9a0e955cbfbf"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_3":{"nodeIds":["6ba6e8d6-ba64-4311-a4f4-175cd2ad7dcd"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_4":{"nodeIds":["17bb435f-0cca-42ae-aadf-4aaaf21fad0c"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_5":{"nodeIds":["c8569f7c-7da0-4f33-a38d-9d4b7d8b892e"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_6":{"nodeIds":["60e1d517-d0b6-4e7a-a6bd-1ebbf9781712"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_7":{"nodeIds":["8e9068b1-c25a-438f-9b6b-b1642e324961"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_8":{"nodeIds":["7d387da3-9158-4462-860e-2854f902cf0e"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_9":{"nodeIds":["ac989ea6-27b2-4709-8f46-3d7b718086ab"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_10":{"nodeIds":["c2eba848-5efa-431c-b51e-03f7c6c6cc8b"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_11":{"nodeIds":["4e8a5d32-0260-4a43-93a2-337edfd6bbad"],"extraInfo":{}},"/Users/deepsun80/Desktop/llamaIndex/Ai.Dit-v1/data/GSOP-708A C&G labs Quality Agreement 2017 Final version.pdf_12":{"nodeIds":["72be6c3e-2b6e-42d9-8512-b68f3837a87f"],"extraInfo":{}}}}